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The main objective of this study is to investigate the occurrence and fate of organic 
micropollutants (OMPs) in surface water in Lake Mälaren over one year, including 
their seasonal variations, correlations between compounds, spatial and vertical distri-
bution. The water samples were enriched with solid phase extraction (SPE) and sub-
sequently analyzed by ultra-high pressure liquid chromatography tandem mass spec-
trometry (UPLC-MS/MS). The applied multi-residue method, consisting of OMPs 
with a wide range of physico-chemical properties was earlier optimized and then as-
sessed regarding its performance. From 122 tested target compounds, 74 obtained a 
good relative recovery (60-145%) and 50 were detected at least once above limit of 
quantification (LOQ), which ranged from 0.010 and 10 ng/L. The highest detected 
concentration was found for valproic acid (2600 ng/L) and lamotrigine (140 ng/L). 
The locations Ekoln and Västeråsfjärden were identified to be most affected by 
OMPs pollution. Seasonal patterns were observed for numerous OMPs and 7 com-
pounds occurred without seasonal fluctuations. Only a few vertical distribution pat-
terns and concentration gradients were observed, for instance, the deepest sampling 
depth (30m) from Ekoln showed considerable higher concentrations than the upper 
sampling depths in February. A strong positive correlation was found for carbamaz-
epine and lamotrigine, but also for other OMPs. Two industrial chemicals, tolyltria-
zole and tris(2-butoxylethyl)phosphate showed very good analytical performance pa-
rameters and were detected frequently and it is recommended to incorporate these 
compounds more regularly in future analysis. No correlations between water chem-
istry were observed. To the best of our knowledge, this study is the first one to report 
the occurrence and distribution of OMPs representing such wide physico-chemical 
properties, including industrial chemicals, in a Swedish lake. 
Keywords: multi-residue method, UPLC-MS/MS, SPE, occurrence, organic mi-
cropollutants, pharmaceuticals, Lake Mälaren, surface water, seasonality 
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It’s a matter of common knowledge, that most of our surface water resources are not 
as clean as they should be. Organic micropollutants (OMP) constitute a group of sub-
stances which are more and more of emerging concern due to their ubiquity in the 
environment and their potential toxicological hazard. Usually the concentrations of 
these compounds are very low ranging from ng/L to µg/L, which can be also ex-
pressed as parts per trillion (ppt) and parts per billion (ppb), respectively. For pur-
poses of clarity one ppm is for example one single black sheep among one billion 
sheep. The unique properties of OMPs can lead to negative effects for aquatic organ-
isms, plants and humans in even such small concentrations. In general, OMP encom-
pass many different kinds of substances such as pharmaceuticals, personal care prod-
ucts, pesticides, perfluoroalkyl substances (PFASs), parabens and industrial chemi-
cals. Usually the primary source for those substances to enter the water are effluents 
of wastewater treatment plants, which are simply not able to remove these kinds of 
substances effectively. The information about the occurrence of substances in a spe-
cific surface water body is important to understand the behavior of these substances, 
potential hotspots where most of them can be found and to identify priorities for fu-
ture actions. The subject of this study was Lake Mälaren, which is the third biggest 
lake in Sweden and the major drinking water source in the Stockholm area. Water 
samples from eleven different sampling locations and eight different sampling 
months (from April ’17 to April ’18) were analyzed regarding 50 different OMPs that 
are widely used in large amounts and are known for possible negative effects in the 
environment.  
All detected concentrations were below estimated acute toxic concerns, however 
not much is known about long-term subtle negative effects and effects when sub-
stances are interacting with each other. Some OMPs were found regularly to almost 
constant concentration levels during the entire year, while most of the OMPs show 
seasonal fluctuations which can be traced back to different usage rates (e.g. antide-
pressants, are a group of pharmaceuticals which are consumed more often in the win-
ter time than during summer) and different elimination rates of OMPs at the 
wastewater treatment plan during the year. The sampling locations Ekoln and Väs-
teråsfjärden are most polluted which is due to the close proximity to densely popu-
lated areas and the outlet of a wastewater treatment plant. In February the highest 
concentrations were found at the bottom of the lake at Ekoln (30 m sampling depth), 
which assumingly causes a higher risk of exposure for those fish which stay there 
during winter time. To the best of our knowledge, some industrial chemicals were 
never analyzed before in Lake Mälaren and surprisingly, two of them (tolyltriazole 
and tris(2-butoxylethyl)phosphate) showed very similar patterns of occurrence com-
pared to, for example, the two pharmaceuticals carbamazepine and lamotrigine, 
Popular science summary 
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which are frequently analyzed and detected in the water. Knowing this, helps to as-
sess the risk that these two industrial chemicals pose. The findings of this study con-
tribute to a better understanding of the behavior of OMPs in surface water and pro-
vide a sound basis for further research. 
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1.1 Background 
Organic micropollutants (OMPs) – also often referred as emerging pollutants (EP) 
–  are a group of compounds that encompass pharmaceuticals, industrial chemicals 
(IC), personal care products (PCP), pesticides, parabens, perfluoroalkyl substances 
(PFASs) and others (Luo et al., 2014). OMPs are to a high extent of anthropogenic 
origin, however can occur naturally as well. They can be detected in various envi-
ronmental matrixes in trace concentrations ranging from few ng/L to several µg/L, 
namely in water, sediments, soil and biota (Nikolaou et al., 2007). Furthermore, 
their fate and transport are complex and dependent on numerous factors, such as 
production, consumption/usage, disposal, transport, removal, transformation, re-
sistance etc. 
In general, emerging contaminants comprises three categories of compounds: 
they were just recently developed and therefore newly introduced into the environ-
ment or they were just recently detected although they are already present in the 
environment for some unknown time or they were only just recently identified as 
being potentially hazardous for the environment and/or humans (Houtman, 2010). 
The common feature shared by these compounds is their ubiquitous nature and the 
absence of guidelines and standards which are adopted to regulate their discharge 
into the aquatic environment (Houtman, 2010; Luo et al., 2014). Regulations only 
exist in a compromised level: The European Union (EU) “watchlist”, a EU-wide 
monitoring mechanism that addresses 10 substances/groups of substances and envi-
ronmental quality standards (EQS) that exist only for a very limited number of com-
pounds (Barbosa et al., 2016). From a national perspective, the Swedish regulatory 
framework merely touches upon pesticides and PFAS’s in drinking water (Tröger 
et al., 2018). The fact, that the majority of about 3000 different substances, used in 
already only human medication in the EU, are not regulated and usually have a ten-
dency to be environmental persistent and biological active gives rise to considerable 
1 Introduction 
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toxicological concern (Fent et al., 2006). Adverse effects that are frequently associ-
ated with the occurrence of OMP’s in the aquatic environment are the antibiotic 
resistance of microorganisms, acute or chronic toxicity, negative effects to non-tar-
get organisms, uncertainties regarding transformation products and metabolites and 
endocrine disrupting effects (Daughton & Ternes, 1999; Pérez-Fernández et al., 
2017). 
Extensive studies targeting OMPs in surface water, in particular, lake basins, are 
limited. This is also the case for Lake Mälaren, Sweden’s third biggest lake which 
is also an important natural drinking water resource, where long-term regular mon-
itoring programs exist (Fölster et al., 2014), but comprehensive data about OMPs 
are not available. 
The sheer amount of OMP, their multi-facetted behaviors and complex correla-
tions of environmental factors underline the challenge to depict fate and transport 
of OMP’s in surface water. In spite of numerous analytical advances, analysis of 
trace compounds in environmental matrices are still challenging regarding its relia-
bility, simplicity, duration, sensitivity and selectivity (Fedorova et al., 2014).  
This study aims to provide a comprehensive data set from a one-year sampling 
period at different locations and sampling depths for Lake Mälaren and moreover to 
contribute to the ongoing assessment of the possible environmental hazards of 
OMPs. 
The main objectives of this study are: 
- To optimize a multi-residue method, based on a single solid-phase-extrac-
tion (SPE) protocol followed by UPLC-MS/MS for the analysis of OMPs in 
surface water 
- To investigate the occurrence of 50 OMPs in Lake Mälaren over one year. 
- To investigate seasonal changes, spatial and vertical distributions of OMP 
concentrations in Lake Mälaren over one year. 
- To study correlations between compounds and water chemistry of Lake    
Mälaren. 
1.1.1 Occurrence of OMPs in the aquatic environment 
A comprehensive understanding of the spatial and temporal occurrence of OMPs is 
essential to identify compounds that require greater attention. By incorporating 
compound and environmental matrix specific properties, conclusions regarding a 
compound’s behavior in the environment can be drawn and will therefore facilitate 
and contribute to future decision-making for defining quality standards and regula-
tions. Exposure and effects of OMPs can only then accurately be evaluated if pro-
found knowledge about fate and transport is acquired (Andreozzi et al., 2003). Car-
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bamazepine, diclofenac, ibuprofen and caffeine are some of the most frequently de-
tected compounds in surface waters (Luo et al., 2014). Bezafibrate, metoprolol, 
iopromide, tramadol, erythromycin, azithromycin and clarithromycin are additional 
compounds usually being associated with a ubiquitous presence in surface water 
(Fent et al., 2006; Ebele et al., 2017; Yang et al., 2017). 
1.1.2 Sources, pathways and removal efficiency 
There are different ways for OMP’s to enter the environment; in general, one can 
differentiate between point and diffuse sources. Point sources are single locations 
that are clearly distinguishable from other pollution sources, whereas diffuse 
sources are rather elusive and are characteristic for broad geographical scales (Lap-
worth et al., 2012). Examples for this are on the one side industrial effluents, hospi-
tal effluents, wastewater and sewage treatment plants, waste disposal sites, septic 
tanks and on the other side storm-water/urban runoffs, agricultural runoffs due to 
application of sewage sludge, leakages from sewer systems (Lapworth et al., 2012; 
Li, 2014). The major identified pathway of introducing OMPs into the aquatic en-
vironment is the effluent of wastewater treatment plants (WWTP) consisting of pro-
cessed influents from domestic, municipal and/or industrial systems (Daughton & 
Ternes, 1999; Choi et al., 2008; Loos et al., 2013). While the final effluent is dis-
charged into surface waters, the remaining residual sludge is either disposed at land-
fills, which can for instance lead to percolation into groundwater, or used as ferti-
lizer and applied to agricultural lands, where run-offs into water bodies are not un-
likely (Daughton & Ternes, 1999; Ebele et al., 2017). Some pharmaceuticals and 
personal care products (PCPs) may be released directly into aquatic bodies via im-
proper disposal of unused medication or recreational activities such as bathing or 
swimming (Daughton & Ternes, 1999; Yang et al., 2017). 
Usually, conventional WWTPs are not designed for the purpose of removing 
OMPs, which is why OMPs are often still present in the effluent (Zorita et al., 2009). 
Whether and how much a compound is removed does not only depend on the design 
of a treatment plant but also on the physico-chemical properties and the frequency 
of introduction of the compounds – some compounds may not be degraded at all or 
only very slow (Yang et al., 2017).  
Differences within the single steps of water treatment and their respective mech-
anisms – primary, secondary and tertiary – are apparent. Several studies investigated 
this and suggest that removal efficiency is insufficient for primary treatment, 
whereas secondary treatment is already much more effective and tertiary treatment 
the most promising option (Altmann et al., 2014; Luo et al., 2014; Falås et al., 
2016). An example of tertiary treatment is the incorporation of granulated activated 
carbon (GAC) filters or ozonation into the operating. When GAC filters are used – 
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as it is the case in the drinking water plant (DWP) at Lake Görväln – regular regen-
eration or replacement are important to ensure continuous high levels of removal of 
OMPs (Tröger et al., 2018). Luo et al. ascertained wide compound-specific varia-
tions in the OMPs removal efficiency for WWTPs ranging from 12.5% to 100% 
(Luo et al., 2014). Despite additional treatment, some compounds might still occur 
in drinking water in usually low concentrations, well below acute toxicity levels 
(Luo et al., 2014; Tröger et al., 2018). 
1.1.3 Natural attenuation process 
Once entered the aquatic environment, the concentration of OMPs is expected to 
decrease with increasing distance to the point of discharge, due to dilution and nat-
ural attenuation mechanisms (Vieno et al., 2005; Daneshvar et al., 2010b). Here, 
sorption and biodegradation are essential processes. However, also photodegrada-
tion is a key factor for natural attenuation. The rate of photodegradation relies on 
the strength of solar irradiation and on the presence of photosensitizer acting sub-
stances to enable photodegradation in the first place (Fent et al., 2006). Although 
natural attenuation mechanisms contribute to a steady decrease of OMP concentra-
tions, spatial distribution and detection in big water compartments, such as Lake 
Mälaren, is not detained.  
1.2 Limitations of the study 
Some OMPs are undergoing transformation through wastewater treatment or human 
extraction so that there are eventually modified and unchanged OMPs discharged 
(Azzouz & Ballesteros, 2013). Modified OMPs, so-called transformation products 
might pose an even higher risk to the environment and humans than the parent com-
pounds. To date, knowledge about occurrence and toxicology of transformation 
products is limited. The present study does not focus on these transformation prod-
ucts of OMPs. 
Due to the vast amount of target analytes, not every single compound will be 
addressed specifically and compared with concentrations presented in the literature. 
In the course of this thesis, some compounds of particular interest are discussed 
more deeply. 
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2.1 Chemicals and consumables 
For chemical analysis, ultrapure water was generated by a Milli-Q (MQ) Advantage 
Ultrapure Water purification system and filtered through a 0.22 µm Millipak Ex-
press membrane and an LC-Pak polishing unit (Merk Millipore, Billercia, MA). 
Methanol, acetonitrile, ammonium acetate, formic acid, ammonia and ethyl acetate 
of high analytical grade were acquired from Sigma-Aldrich (Sweden). 
All analytical standards used for analysis were of high purity grade (>95%). Na-
tive standards (n=122) originate from Sigma-Aldrich (Sweden). Isotopically labeled 
standards (IS) (n=26) for the target compounds were obtained from Wellington La-
boratories (Canada), Teknolab AB (Kungsbacka, Sweden), Sigma-Aldrich and To-
ronto Research Chemicals (Toronto, Canada). Detailed information about internal 
and native standards can be found elsewhere (Rostvall et al., 2018).  
Several consumables were used in the present study, mainly for sample prepara-
tion. For SPE empty polypropylene (PP) tubes (6 mL) and sorbent materials Sepra 
ZT (Strata-X), Sepra ΖΤ-WCX (Strata-X-CW) and ΖΤ-WAX (Strata-X-AW) were 
acquired from Phenomenex (Torrance, USA). The sorbent material Isolute ENV+ 
and the frits (20 μm, 6 mL) were obtained from Biotage (Ystrad Mynach, UK). The 
samples were filtered using a glass microfibre filter (grade GF/F, Whatman, thick-
ness 0.42 mm, pore size 0.7 μm) and regenerated cellulose syringe filters (RC) of 15 
mm diameter and 0.2 μm pore size purchased from Millipore (Cork, Ireland) and 
Phenomenoex(Torrance, CA, USA), respectively, were used.  
2 Materials and Methods 
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2.2 Selected compounds 
In total 122 compounds were evaluated in the present study, consisting of 80 phar-
maceuticals, 19 industrial chemicals, 7 personal care products, 3 pesticides, 3 vita-
mins, 3 parabens, 2 artificial sweeteners, 2 stimulants, 1 contrast medium, 1 opioid 
and 1 isoflavone. The pharmaceuticals cover several different therapeutic groups, 
such as analgesics, anesthetics, antibiotics, anticancer, antidepressants, antidiabet-
ics, antidiarrhoeal, antifungals, antihistamines, antihypertensives, antilipemic 
agents, antimalarials, antipsychotic, antisecretory agent, beta blockers, diuretics, 
nonsteroidal anti-inflammatory drugs (NSAID) and sedatives. 
The multiresidual approach of this study was based on a method developed in 
the Department for Aquatic Sciences and Assessment SLU, which focused on an 
array of OMP’s that were chosen due to their high annual consumption and wide 
scope of application in the private sector and their continuing concern about their 
possible adverse effect on humans and aquatic organisms. 
This target screening method was optimized by testing 35 additional compounds 
on a triple-stage quadrupole mass spectrometer MS/MS TSQ QUANTIVA (Thermo 
Fisher Scientific). A compound was incorporated in the method if the instrument 
was able to ionize the compound and its fragments could therefore be determined in 
order to quantify and qualify the compound. This is essential to avoid false positive 
identification of compounds (Krauss et al., 2010). Additionally, the chromatograph-
ical column had to be able to separate the target compounds from endogenous sub-
stances with similar retention times and the LOQ shouldn’t be too high. Out of the 
35 tested compounds, 21 were added to the final analytical method.  
2.3 Study site and sample collection.  
Mälaren Lake is the third biggest lake in Sweden. It is the major supply for drinking 
water production in the Stockholm area and at the same time a receiving water body 
for several wastewater treat-
ment plants (Swedish EPA, 
2017). The lake is enclosed by 
Stockholm to the east, Uppsala 
to the north and Västerås to the 
west. The Mälaren area is con-
sidered as one of the fastest 
economically expanding re-
gions in Sweden and at the 
same time, Stockholm has the 
Figure 1. Sampling on the 11th of November 2017. 
Skarkolmen Uppsala. 
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greatest increase in population increase in Europe (11% in the next five years) 
(WssTP, 2013). 
The lake’s surface area is 1140 km², maximum depth is about 64 m and the water 
residence time is 2.8 years  (Wallin et al., 2000; Daneshvar et al., 2010a). The sur-
rounding area is characterized by 57% forest area, 20% agricultural area and 11% 
water bodies (Sonesten et al., 2013). The lake basin has a branched structure which 
entails various bays of different shapes and depths (Willén, 2001; Moore et al., 
2008). This allows to divide the lake into different basins and to regard it separately. 
There are 12 incoming rivers to Mälaren: Arbogaån, Hedströmmen, Köpingsån, 
Kolbäcksån, Eskilstunaån, Svartån, Sagån, Råckstaån, Örsundaån, Fyrisån, 
Märstaån and Oxundaån (from west to east) (Sonesten et al., 2013). The map (figure 
2) gives a good overview of the described sampling site. 
Eight different sampling events were conducted in the course of this study, starting 
in February 2017 and followed by April, May, July, August, September, November 
and April 2018. In total, 11 sampling points were part of the study: Galten, Blacken, 
Västeråsfjärden, Granfjärden, Svinnegarnsviken, Ulvhällsfjärden, Prästfjärden, S. 
Björkfjärden, Ekoln, Skarven and Görväln. However, the sampling sites varied 
slightly during the sampling period, and only 5 locations were consistently collected 
throughout most of the period: Ekoln, Galten, Görväln, Skarven and Väster-
åsfjärden. Usually, surface water (0.5m) were collected for the different locations, 
Figure 2. Map of Mälaren showing the sampling sites, incoming streams and the theoretical division of Lake Mälaren in six 
basins (A-F) (Sonesten et al., 2013). 
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with the exception of Ekoln, Görväln and in one occasion Prästfjärden, which were 
sampled for three different depths (0.5 m, 15 m, 30 m or 40 m). The appendix table 
A4 contains a detailed list of the exact sampling points of this study.  
2.4 Sample preparation 
Water samples were taken as grab samples in 1 L PP-
bottles during the period from February 2017 to 
April 2018. Sampling bottles were rinsed three times 
before being filled. In total, 84 samples were ana-
lyzed. All samples were stored at 8°C at the Depart-
ment for Aquatic Sciences and Assessment at SLU. 
Detailed information about the sampling sites, dates 
and location can be found in table A4 in the in ap-
pendix. 
For the SPE analysis, 500 mL of the aliquots were 
used. Before extraction, all samples including blanks 
were vacuum filtered to remove suspended solids 
and avoid subsequent clogging during SPE. The 
glass microfiber filter used (grade GF/F, Whatman, 
thickness 0.42 mm, pore size 0.7 µm) were burned 
at 400°C for four hours before use. By thoroughly 
shaking the samples before the filtration it was en-
sured to obtain homogenized samples. The filtration 
unit was cleaned with MQ water and methanol be-
tween different samples. The instrumental setup of 
the filtering unit is shown in Figure 2.  
As the extracted samples will be used for a following study focusing on non-
target screening, the extraction materials chosen for the present study needed to be 
compatible with the subsequent method and support it. The combined results of the 
present target-based study and the nontarget analysis allow a holistic environmental 
risk assessment (Gago-Ferrero et al., 2015a). Due to this reason, SPE was conducted 
with home-made cartridges following the method developed by Gago-Ferrero et al. 
(2015a; b). For the purpose of covering a broad range of compounds and enabling 
their enrichment, four different powder materials were selected and mixed together 
(200 mg Strata-X, 150 mg Isolute ENV+, 100 mg Strata-X-AW and 100 mg Strata-
X-CV) (Gago-Ferrero et al., 2015b). An illustration of the composition of a car-
tridge can be found in figure A2 in the appendix.  
The samples were spiked with the IS mix (50 ng/ per sample aliquot before SPE). 
Figure 3. Set-up of filtering unit. 
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In the first step of SPE extraction, cartridges were conditioned (by gravity) in 
two steps by adding 6 mL of methanol and 6 mL of MQ water into the reservoirs. 
Reservoirs got loaded and the flow rate was adjusted to roughly one drop per second 
by means of vacuum. Another 6 mL of MQ was added after all the aliquot ran 
through and the cartridges were dried under 
vacuum for 20 min.  
The eluate is collected in plastic tubes after 
adding 4 mL of methanol/ethyl acetate (1:1) 
containing 2 % ammonia directly into the car-
tridge, followed by 2 mL of methanol/ethyl ac-
etate (1:1) containing 1.7 % formic acid. This 
step was done under gravity.  
To decrease the volume of the extract, nitro-
gen stream is applied until a volume of approx-
imately 1 mL is reached, then transferred to an 
amber glass vial, rinsed 3 times with methanol 
and evaporated again to exact 500 µL. Analytes 
are vortexed and 500 µL of MQ water is added 
before analysis. 
The set-up of the SPE extraction including 
manifold, adapters, stop-cocks, reservoirs and 
vacuum outlet is shown in figure 3. 
2.5 Instrumental analysis 
The need to analyze complex sample matrixes with unknown interferences, such as 
environmental samples, is widely met with coupling a separation technique with an 
identification and quantification method, represented by chromatography and mass 
spectrometer (MS).  
For liquid chromatography (LC), the two key elements for the separation of com-
ponents in the sample are a liquid mobile phase in which the analytes are diluted, 
and a stationary phase represented by the column (Skoog et al., 2017). The physical-
chemical properties of a compound determine its characteristic retention time, 
which is needed to identify it – the polarity of a compound plays a pivotal role in 
this process. The choice of column considerably affects the resolution and run time 
in LC. 
Before the analysis in the mass spectrometer, the compounds need to be ionized. 
Electrospray ionization (ESI) is a rather soft liquid-phase ion source which has a 
Figure 4. Set-up of SPE, showing the car-
tridges, loaded reservoirs, valves, stock-
cocks and manifold. 
22 
 
very high sensitivity to the concentration of a compound and works in an appropriate 
way in combination with LC (Hoffmann & Stroobant, 2007). 
A commonly used method for target analysis is the triple quadrupole mass spec-
trometer, which however exhibits restrictions for suspect and non-target screening 
(Krauss et al., 2010). The operating principle can be described in a three-step pro-
cess involving two stages of mass analysis (MS/MS). Firstly, a mass spectrometer 
filters a precursor ion, which is then dissociated into fragments within the collision 
cell and lastly the resulting product spectrum is analyzed by the second mass spec-
trometer (Hoffmann & Stroobant, 2007). 
The samples were analyzed by a DIONEX UltiMate 3000 ultra-high pressure 
liquid chromatography (UPLC) system (Thermo Scientific, Waltham, MA, USA) 
coupled to a triple quadrupole mass spectrometer (MS/MS) (TSQ QUANTIVA, 
Thermo SCIENTIFIC, Waltham, MA, USA). An Acquity UPLC BEH-C18 column 
(Waters, 100 mm × 2.1 i.d., 1.7 µm particle size from Waters Corporation, Man-
chester, UK) was used as an analytical column. Injection volume was 10 µL for all 
samples. A heated electrospray ionization (H-ESI) was used to ionize the target 
compounds. The spray voltage was set to static: positive ion (V) 3500. Nitrogen 
(purity >99.999%) was used as a sheath gas (50 arbitrary units), auxiliary gas (15 
arbitrary units) and sweep gas (2 arbitrary units). The vaporizer was heated to 400°C 
and the capillary to 325°C. Two selected reaction monitoring (SRM) transitions 
were monitored for all analytes. The mobile phase consisted of MQ with 5 mM 
ammonium acetate and acetonitrile. The flow rate was 0.5 mL/min and run time was 
15 min having switched positive and negative electrospray ionization modes. 
The above-mentioned ionization conditions were set as tuning conditions for the 
SRM of individual compounds. The tuning was performed with an infusion of 1 
µg/mL solution of each analyte into the stream of the mobile phase (300 mL/min of 
MQ water + 5 mM ammonium acetate/acetonitrile, 50/50). The tube lens voltage 
and collision energy of the two most abundant transitions were optimized. 
The chromatography data acquisition mode was performed in a positive and neg-
ative mode using selected-reaction monitoring. Xcalibur software (Thermo Fisher 
Scientific, San Jose, CA, USA) software was used for optimizing the instrument 
methods and running of samples. The obtained data were evaluated using Trace-
FinderTM 3.3. software (Thermo Fisher). 
2.6 Method performance 
The performance of the method was assessed with regard to its linearity, LOQs, 
relative recovery, precision, blanks and matrix effect. 
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For testing the linearity of the method, a ten-point calibration curve in the con-
centration range from 0.01 ng/L to 250 ng/L was created. For each separate analysis, 
the calibration curve was measured twice, at the beginning and at the end of the 
sequence to check instrumental stability. The linearity of the calibration curve was 
validated by calculating the coefficient of determination R². 
Instrumental LOQ’s were calculated as one half of the lowest calibration point 
in the calibration curve where relative standard deviation of average response factor 
(ARF) was < 30% (in some cases one or two points at low concentration levels had 
to be removed). LOQs for each analyte in each sample were calculated by using the 
peak area of the lowest calibration point in the calibration curve. Average, minimum 
and maximum values of LOQ of the particular analytes can be found in table A1 in 
appendix. 
The relative recovery, also known as trueness, verifies the performance of the 
extraction method (SPE, UPLC-MS/MS). This is done by spiking a known concen-
tration of target analytes into the water samples (100 ng/sample) and correlate it 
with the detected concentration after extraction and analysis – so-called fortified 
samples. 
The precision of the method is evaluated by the repeatability of the study. For 
this purpose, duplicates were conducted for every tenth sample. The values allow 
the comparison of the analysis within a batch of samples and between different 
batches. The repeatability is calculated by the ratio of standard deviation of the du-
plicates and the average detected concentration of the compounds times 100. Opti-
mal repeatability rates are lower that 30%.   
Quantification of the target compounds is done by using an internal standard (IS) 
calibration model. An optimized quantification of the analytes was established by 
combining four calibration curves and hence, to smooth possible outliers.  
As the mass and retention time of a compound is relevant for the detection by 
UPLC-MS/MS, the optimal approach would be to use an isotopically labeled form 
for each of the target compounds, as it is stated in the Commission Decision 
2002/657/EC (European Commission, 2002). For target compounds that could not 
be matched with a specifically designed IS due to restricted commercial availability, 
a surrogate IS needed to be selected. This was the case in particular for the newly 
tuned compounds. The chosen IS should reflect the physical-chemical properties, 
retention time and categorial grouping of the compound as much as possible. This 
step is also essential to obtain acceptable recovery rates for the compounds. 
A mix of endogenous substances, such as proteins, lipids, minerals, salts and 
others can considerably affect the extraction and analysis. This phenomenon is com-
monly termed matrix effect. The resulting effect of ion suppression or enhancement 
were taken into consideration by matrix matching standards (MST). As the matrix 
effect can differ with the different compositions of the samples, the MST’s were 
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chosen in such way that the most frequent locations Ekoln, Görväln, Skarven, Gal-
ten and Västeråsfjärden were covered and could be therefore assigned to the respec-
tive sample. For Ekoln and Görväln MST values for the different depths were de-
termined and were incorporated as an average value in the calculation of real con-
centrations of the samples. Those samples that are not directly presented by a cor-
responding MST from the respective location, the real concentrations were calcu-
lated by using the MST with the highest matrix effect.  
Matrix-matched standards were prepared from water samples spiked with ISs at 
concentration levels of 50 ng per sample and native compounds at concentration 
levels of 100 ng per sample after extraction. The peak area/IS ratio determined in 
non-spiked samples was subtracted from the peak area/IS ratio in matrix-matched 
standards to achieve the matrix-affected response factor. Additionally, matrix ef-
fects were calculated and are presented in table A2 in the appendix. Negative values 
are associated with ion suppression whereas positive values are associated with ion 
enhancement. 
To exclude any concerns of contamination and evaluate possible memory ef-
fects, each batch of analysis was conducted with two blanks, MQ water and tap 
water, which were filtered, extracted, eluted and analyzed in the exact same way as 
the samples. PP-bottles and SPE reservoirs were rinsed three times with methanol; 
adapters, stop-cocks from the SPE and needles from the evaporation step were ul-
trasonicated twice for 15 min. All analytical work was conducted while wearing 
gloves.  
Method performance parameters (R², repeatability; relative recovery) are shown 
in table 1 in paragraph 3.1. 
2.7 Statistical analysis 
The statistical program JMP from SAS institute was used for data analysis, graphical 
processing and statistical tests, notably principle component analysis (PCA) and 
partial least square (PLS) analysis. In addition, the spreadsheet program Microsoft 
Excel was used to calculate concentrations and data analysis. For maximum, median 
and average values, only concentrations >LOQ were used. 
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3.1 Method performance 
 In the present study, 122 compounds were evaluated in the course of SPE and 
UPLC-MS/MS. In spite of prior tuning, throughout the analysis it became apparent, 
that 11 compounds were not able to be analyzed in a qualitative and quantitative 
way. These 11 substances consist of 6 ICs, 4 pharmaceuticals and one PCP. Reasons 
for omission became mostly clear during acquiring the data via the software Trace-
Finder. No clearly detected peaks, no sufficient chromatographic separation, a lack 
of ionization of the compound to determine a qualitative and quantitative fragment 
or high variability in the results, no linear response of the calibration curves were 
the main reasons for excluding those compounds. Due to their vast diversity, 
knowledge about industrial chemicals, their behavior and analytical protocols for 
their determination in environmental samples is limited or lacking completely – as 
it is the case of sebacic acid, tetraethylene glycol, dibutyl thiourea, tetraacetyleth-
ylenediamine (TAED), mono-n-butylphosphoric acid and 4-dodecylbenzenesul-
fonic Acid. Three of the omitted compounds are part of the EU-Watchlist: the two 
macrolide antibiotics azithromycin and erythromycin and the UV-filter 2-ethyl-
hexyl-methoxycinnamate. The difficulties to analyze these compounds are well 
known in the literature. Instead of the chosen UPLC-MS/MS set-up of the present 
study, variations in the sample preparation, liquid phase, ion source, column etc. 
will achieve considerable different results (Pérez-Fernández et al., 2017). For in-
stance, using atmospheric pressure photoionization (APPI) instead of H-ESI as an 
ion source will yield much better outcomes for some compounds (Lindberg et al., 
2014).  
For 74 OMPs of the remaining 111 OMPs the method was suitable by obtaining 
a relative recovery within the range of 60% to 145%, thus leading to the exclusion 
of 23 pharmaceuticals (including clarithromycin, the third macrolide antibiotic on 
3 Results and Discussion 
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the EU-Watchlist), 6 ICs, 4 PCPs, 3 vitamins and 2 artificial sweeteners due to un-
acceptably low recovery rates and therefore restrictions in their quantification. For 
22 OMPs the recovery rate was under 60% with ricinoleic acid having the lowest 
recovery rate of 3%, for 13 OMPs the recovery rate was above 145% with oleic acid 
having the highest recovery rate of 624%, and 3 times no recovery rate was obtained 
as the LOQs were too high. 15 additional compounds are within the range of 40% 
to 160%. The bad recovery rates of the 23 OMPs imply that using the described 
method is not appropriate and different methods, more targeted towards their spe-
cific analysis requirements, are needed.  
As the target analytes of the present study are quite heterogeneous and cover a 
wide range of physico-chemical properties, finding conditions that attain acceptable 
chromatographic behaviors to adequately quantify the compounds is a complicated 
matter (Grabic et al., 2012). For instance, different mobile phases can improve the 
chromatographic performance regarding reduced peak tailings and better resolu-
tions for some compounds considerably – for some compounds the effect may, how-
ever, entail the complete opposite (Baker & Kasprzyk-Hordern, 2011). Whatever 
condition is chosen, it is an issue that constitutes a compromise for the analytes in 
terms of sensitivity and selectivity but ultimately seeks a good overall performance 
(Huntscha et al., 2012). The choice of sorbent material for SPE is essential to attain 
good recovery rates (Baker & Kasprzyk-Hordern, 2011; Pérez-Fernández et al., 
2017). Not only were the powder sorbents used in the present study originally cho-
sen for a non-target analysis, but also do home-made cartridges entail a certain un-
certainty as a 100% homogeneity of the cartridges cannot be guaranteed. Investigat-
ing factors like the applied temperature during the evaporation step, vials, sample 
volumes, filters being used,  are important to consider to achieve optimized recovery 
rates (Baker & Kasprzyk-Hordern, 2011). SPE related issues are partially discussed 
in Gago-Ferrero et al. (2015a; b) For future analysis a method adaptation is recom-
mended, in particular regarding the choice of cartridges for SPE extraction.  
Individual LOQs for each compound in each sample are summarized in average, 
minimum and maximum values and are presented in table A1 in the appendix for 
only the 50 OMPs which were detected at least once above the LOQ and not re-
moved for some other reason (see paragraph 3.2.1). The same applies to repeatabil-
ity and linearity. Those compounds which attained good recovery rates, however 
were not detected above LOQ are listed in table A3 in the appendix including re-
covery rates and linearity. 
The range for the LOQsaverage for the 50 OMPs reaches from 0.010 to 5.0 ng/L 
(median 0.090 ng/L), for LOQsmin from 0.0070 to 3.9 ng/L (median 0.062 ng/L) and 
for LOQsmax from 0.020 to 10 ng/L (median 0.26 ng/L). For four compounds LOQs 
> 5.0 ng/L were occasionally calculated: acetaminophen (LOQaverage = 5.0 ng/L), 
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ibuprofen (LOQaverage = 5.0 ng/L), valproic acid (LOQaverage = 3.6 ng/L) and 3-(4-
methylbenzylidene)camphor (LOQaverage = 3.3 ng/L). 
The instrumental analysis of the present study shows good linearity for the ma-
jority of compounds (R² > 0.980), with the exception of atenolol (R² = 0.961) and 
irbesartan (R² = 0.975). 
Sample duplicates with high frequencies of detection are the most suitable ones 
to show the repeatability of the used method. For this reason, only duplicates from 
Ekoln, Västeråsfjärden, Blacken and fortified samples are presented in table 1. 
Looking at the fortified samples, only one analyte exceeded the 30%, namely lido-
caine (55%). Lidocaine, however, showed good repeatability rates for the other du-
plicates. Besides that, 88% of the duplicates show a good precision (<30%) of the 
SPE analysis. 
Matrix effects are presented in table A2 in the appendix and show a good com-
parability of the different sampling points. High ion suppression or enhancement of 
an analyte in one of the sampling sites is usually reflected in the other sampling sites 
as well. No evident deviation for any of the matrix matching samples was observed, 
so that assigned MSTs for the calculated concentrations are approved. Seemingly 
arbitrary behaviors arise for: atenolol, bicalutamide, clozapine, irbesartan, amitrip-
tyline, valproic acid and venlafaxine. In most cases, the deviating matrix effect 
stems from Västeråsfjärden, or occasionally from Ekoln. Greater polluted water in 
conjunction with the proximity to a large city likely contains more matrix com-
pounds that might explain the alteration in detected concentrations of analytes.  
Some studies suggest correlations between polarity and molecular weight of the 
compounds with matrix effects (Cappiello et al., 2010). However, no evident corre-
lations could be found. Considerable high matrix effects were obtained for daidzein 
(range -170% to 349%), di-(2-ethylhexyl)phosphoric acid (range -101% to 122%) 
and  lamotrigine (range -246% to 280%, Görväln 2018: 21%). For venlafaxine, there 
is an outlier value (437%) for MST Ekoln, although all the matrix effects of the 
other sampling points range from -8% to 41%. 
17 industrial chemicals were tested in the course of this study. Although several 
IC were priorly tuned on the method and some of them even incorporated into the 
method, it became apparent that the method is rather unfitting due to largely not 
acceptable recovery rates and high variability in the results. Only 7 IC had a good 
recovery and from those 4 IC were detected above the LOQs. ICs were not part of 
the original developed analytical method. To my best knowledge, for some com-
pounds an analytical protocol for their determination in environmental samples is 
not yet known. 
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Table 1. Physico-chemical properties, relative recovery, coefficient of determination R², repeatability of duplicates and frequency of detection of positive analytes. In total 84 
samples were analyzed. (pKa: acid dissociation constant; log Kow: water partition coefficient) 
        Repeatability  
Compound Category Type 
Monoisotopic 
mass (Da) pKa log Kow 
Relative 
Recovery R² 
Ekoln 
(0.5m) 
Ekoln 
(15m) Blacken 
Fortified 
Samples 
Frequency of 
Detection 
Atenolol Pharmaceutical Beta blocker 266.2 9.6 a 0.16 99% 0.9613 n.d. 5% 1% 4% 46% 
Sotalol Pharmaceutical Beta blocker 272.1 8.3 a 0.37 114% 0.9962 n.d. 141% n.d. 4% 8% 
Nicotine Stimulant  162.1 3.2 a 1.0 104% 0.9994 1% 2% n.d. 1% 23% 
Metoprolol Pharmaceutical Beta blocker 267.1 9.7 b 1.7 94% 0.9965 0% 2% 3% 12% 88% 
Atorvastatin Pharmaceutical Antilipemic drug 558.2 4.3 b 6.4 99% 0.9969 n.d. n.d. n.d. 5% 18% 
Carbamazepine Pharmaceutical Antiepileptic 236.0 4.2 a 2.3 99% 0.9903 1% 2% 8% 10% 99% 
Cetirizine Pharmaceutical Antihistamine  388.9 2.7 b 1.7 73% 0.9895 23% 17% 1% 31% 87% 
Citalopram Pharmaceutical Antidepressant 324.1 9.4 a 3.7 62% 0.9994 3% 9% 53% 6% 63% 
Mirtazapine Pharmaceutical Antidepressant 265.1 7.1 a 3.0 73% 0.9985 16% 8% n.d. 2% 50% 
Oxazepam Pharmaceutical Sedative 286.0 1.7 a 3.3 83% 0.9961 3% 2% 10% 4% 88% 
Pyrimethamine Pharmaceutical Antimalarial 248.1 7.3 a 2.7 83% 0.9901 n.d. n.d. n.d. 3% 6% 
Lamotrigine Pharmaceutical Antiepileptic 255.0 5.7 a 0.99 120% 0.9884 3% 2% 10% 29% 100% 
DEET Pesticide Insect repellent 191.1 - 2.3 94% 0.9980 1% 1% 4% 5% 100% 
Bezafibrate Pharmaceutical Antilipemic drug 361.1 3.6 a 4.3 88% 0.9961 n.d. n.d. n.d. 4% 20% 
Sulisobenzone PCP UV filter 308.0 -2.4 b 0.37 83% 0.9971 9% 42% n.d. 5% 62% 
Dibutyl phosphate Industrial Chemical Lubricant 210.2 0.88 b 2.3 104% 0.9982 n.d. n.d. 86% 7% 52% 
Tolyltriazole Industrial Chemical Corrosion inhibitor 133.2 8.4 a 1.7 114% 0.9997 1% 5% 6% 9% 100% 
Ifosfamide Pharmaceutical Anticancer 260.0 - 0.86 88% 0.9917 2% 49% n.d. 1% 24% 
Bicalutamide Pharmaceutical Anticancer 430.4 13 2.3 130% 0.9983 2% 2% 2% 1% 100% 
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        Repeatability  
Compound Category Type 
Monoisotopic 
mass (Da) pKa log Kow 
Relative 
Recovery R² 
Ekoln 
(0.5m) 
Ekoln 
(15m) Blacken 
Fortified 
Samples 
Frequency of 
Detection 
Bisoprolol Pharmaceutical Antihypertensive 325.4 9.3 b 1.8 99% 0.9975 5% 2% 1% 4% 76% 
Clozapine Pharmaceutical Antipsychotic 326.1 3.6 a 3.4 78% 0.9880 12% n.d. n.d. 2% 19% 
Diazepam Pharmaceutical Sedative 284.0 3.3 a 2.7 88% 0.9835 29% 28% 23% 3% 37% 
Fexofenadine Pharmaceutical Antihistamine 501.7 8.8 b 2.8 83% 0.9918 7% 1% 2% 6% 86% 
Caffeine Stimulant  194.1 10 a -0.07 99% 0.9985 3% 9% 4% 1% 100% 
Tramadol Pharmaceutical Analgesic 263.1 9.4 a 3.0 109% 0.9954 6% 3% 7% 4% 82% 
Valsartan Pharmaceutical Antihypertensive 435.2 3.8 b 3.7 109% 0.9982 n.d. n.d. n.d. 7% 18% 
Codeine Pharmaceutical Opiate 299.1 8.2 a 1.3 78% 0.9979 n.d. n.d. n.d. 1% 10% 
Oxycodone Opioid  315.1 8.9 a 0.66 78% 0.9981 15% 8% n.d. 13% 25% 
2,2'-Dimorpholinyldiethylether Industrial Chemical Process regulator 244.2 - -1.3 83% 0.9995 19% n.d. n.d. 8% 19% 
Diclofenac Pharmaceutical NSAID 295.0 4.2 a 4.0 88% 0.9972 n.d. 24% n.d. 10% 37% 
Ethylparaben Paraben Preservative 166.0 8.3 a 2.5 109% 1.0000 n.d. n.d. n.d. 6% 11% 
Propylparaben Paraben Preservative 180.0 8.4 a 3.0 94% 0.9990 n.d. n.d. n.d. 0% 42% 
Methylparaben Paraben Preservative 152.0 8.4 a 2.0 104% 1.0000 n.d. n.d. n.d. 1% 33% 
Furosemide Pharmaceutical Diuretic 330.0 4.3 b 2.3 88% 1.0000 n.d. n.d. n.d. 1% 21% 
Diltiazem Pharmaceutical Antihypertensive 414.1 7.7 a 2.8 88% 0.9976 n.d. n.d. n.d. 1% 10% 
Ibuprofen Pharmaceutical NSAID 206.1 4.4 a 3.8 78% 0.9979 n.d. n.d. n.d. 7% 2% 
Irbesartan Pharmaceutical Antihypertensive 428.2 3.5 b 5.3 94% 0.9753 2% 1% 1% 1% 62% 
Propranolol Pharmaceutical Beta blocker 259.1 9.5 a 2.6 125% 0.9986 33% 16% 2% 1% 52% 
Lidocaine Pharmaceutical Anesthetic 234.1 8.0 a 1.7 135% 0.9979 0% 1% 0% 55% 85% 
Losartan Pharmaceutical Antihypertensive 422.1 4.1 a 4.0 94% 0.9891 0% 2% 6% 2% 62% 
Omeprazole Pharmaceutical Antisecretory Agent 345.1 4.8 b 3.4 94% 0.9959 n.d. n.d. n.d. 11% 7% 
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        Repeatability  
Compound Category Type 
Monoisotopic 
mass (Da) pKa log Kow 
Relative 
Recovery R² 
Ekoln 
(0.5m) 
Ekoln 
(15m) Blacken 
Fortified 
Samples 
Frequency of 
Detection 
Acetaminophen Pharmaceutical Analgesic 151.0 9.4 a 0.46 94% 0.9939 n.d. n.d. n.d. 14% 1% 
Amitriptyline Pharmaceutical Antidepressant 277.1 9.4 a 5.0 109% 0.9966 n.d. n.d. n.d. 6% 14% 
Valproic acid Pharmaceutical Antiepileptic 144.1 4.6 a 3.0 114% 0.9992 n.d. n.d. 141% 13% 43% 
Venlafaxine Pharmaceutical Antidepressant 277.2 9.3 b 3.3 83% 0.9992 11% 16% n.d. 2% 71% 
Daidzein Isoflavones  254.1 - 2.6 94% 0.9642 n.d. n.d. n.d. 2% 8% 
Di-(2-ethylhexyl)phosphoric 
acid 
Industrial Chemical Solvent Extraction 322.2 - 6.1 104% 0.9959 n.d. n.d. 2% 10% 18% 
Tris(2-butoxylethyl) phosphate Industrial Chemical Flame retardants 398.5 - 3.8 94% 0.9997 18% 4% n.d. 0% 76% 
3-(4-Methylbenzylidene)cam-
phor 
PCP UV filter 254.2 - 5.9 62% 0.9995 n.d. n.d. n.d. 27% 4% 
Fluoxetine Pharmaceutical Antidepressant 309.1 10 b 4.7 114% 0.9880 n.d. n.d. n.d. 7% 1% 
a experimental pKa, b theoretical pKa 
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3.2 Occurrence of OMPs 
3.2.1 OMP concentrations 
Out of the 74 OMPs with good relative recovery, 58 compounds were detected at 
least once above the limit of quantification. 
Laurilsulfate was removed despite a good recovery rate. It was detected only 
once in one of the duplicates which results in an unacceptable repeatability value of 
141%. Despite of good repeatability in the fortified samples, the high variability of 
the concentrations of samples, the repeatability and LOQs (variance 119%) led to 
the decision to remove the compound.  
This also applies for the plasticizer Tributyl citrate acetate in a similar way. Low 
relative recovery (62%), unacceptable repeatability and high variability in concen-
trations led to its omission.  
Antibiotics and antifungals had to be removed as well. Six pharmaceuticals be-
long to this group: metronidazole, metronidazole-OH, sulfamethoxazole, trime-
thoprim, clindamycin and climbazole. The compounds were omitted due to stability 
issues of internal and native standards. As it is suggested in literature (Ort et al., 
2010), freshly prepared standard mixed are crucial to obtain reliable results. Unfor-
tunately, this was not assured. 
Comprehensive monitoring studies focusing on OMPs in surface water are rare, 
especially with regard to lake basins. As river water is usually more directly affected 
by WWTPs effluents and dilution differs in terms of magnitude, a comparison of 
the obtain concentrations of the present thesis with other studies is impeded.  
Five analytes were found in all sampling points: DEET, lamotrigine, bicalutam-
ide, tolyltriazole and caffeine. Very high frequencies of detection (>80%) above 
LOQs were also obtained for carbamazepine (99%), metoprolol (88%), oxazepam 
(88%), cetirizine (87%), fexofenadine (86%), lidocaine (85%) and tramadol (82%). 
The highest detected concentrations (> 100 ng/L) were found for valproic acid and 
lamotrigine. Figure 4 illustrates the 20 compounds found with the highest concen-
trations, their median concentration and frequency of detections. Due to the long 
sampling period, some compounds have considerable fluctuating concentrations, 
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with occasional high concentrations. To place less weight on these very high con-
centrations, median instead of average concentrations were chosen to be displayed. 
In general, the median is less affected by outliers and has advantages in particular 
when the distribution of a data is not symmetrical. 
Carbamazepine, valproic acid and lamotrigine are the most frequently prescribed 
antiepileptics, accounting for 72% of initiating monotherapies in Sweden; with an 
increasing trend to lamotrigine (Bolin et al., 2017). Since the physico-chemical 
properties of lamotrigine and carbamazepine are very similar, both antiepileptics, 
their behavior and occurrence usually go hand in hand (see paragraph 3.3). Numer-
ous studies evince the low elimination rates of carbamazepine in WWTP (Li, 2014; 
Ebele et al., 2017). Neither sorption, biodegradation nor photodegradation seems to 
achieve good removal outcomes (Fent et al., 2006).  Maximum (27 ng/L and 140 
ng/L) and median (6.2 ng/L and 18 ng/L) detected concentrations for carbamazepine 
and lamotrigine, respectively, are within usually expected ranges. A sampling event 
in Lake Mälaren conducted by Daneshvar et al. (2010a) detected higher concentra-
tions by roughly 8 orders of magnitude for carbamazepine (Daneshvar et al., 2010a). 
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Figure 5. Top 20 highest detected OMPs throughout the entire sampling period of one year. The figure shows the maximum 
detected concentration, the medium concentration and the frequency of detection of the specific compound. In total 84 samples 
were analyzed. 
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Valproic acid is the compound found with the highest concentrations ranging 
from 2.1 ng/L to 2600 ng/L with the median concentration 17.5 ng/L. Information 
about biodegradation and removal efficiency are inconsistent. According to the 
website TOXNET, bioconcentration in aquatic organisms is unlikely due to a bio-
concentration factor (BCF) of 3 (TOXNET), whereas at the same time valproic acid 
was observed to change social interactions between zebrafishes (Zimmermann et 
al., 2015), however, the Stockholm County Council determines the environmental 
risk of valproic acid as insignificant but also states the uncertainty of the assessment 
due to lack of data (Stockholm County Council, 2014). No clear conclusion regard-
ing the toxicological effect of valproic acid in Lake Mälaren can be drawn. 
The ubiquitous nature of caffeine is not surprising, as it is widely known that 
caffeine is simply found everywhere; its concentration can even reach up to a few 
µg/L (Sousa et al., 2018). In that perspective, the highest detected concentration of 
79 ng/L and median concentration of 13 ng/L are acceptable. 
Similar holds true for the insect repellent DEET (diethyltoluamide) which is 
quite usually found in high frequencies in surface water (Sandstrom et al., 2005). 
Maximum (8.3 ng/L) and median concentrations (1.95 ng/L) are low.  
According to Daneshvar et al., metoprolol is “the most sold beta-blocker in Upp-
sala”, and annual sales are more than twice as much as the beta-blocker atenolol 
(Daneshvar et al., 2010a). Maximum concentration is 18 ng/L, median concentra-
tion 5.23 ng/L. These results are well comparable to the concentrations found by 
Daneshvar et al. (2010a) in Lake Mälaren; also regarding maximum and median 
concentrations found for atenolol, which are just slightly lower. The reason for this 
seems to be differences in removal efficiencies of WWTPs and excretion ratios of 
parent compound or metabolites (Daneshvar et al., 2010a).  
Tramadol is an analgesic drug used for moderate to severe pain relieve (WHO, 
2014). It is mainly present in soluble form as volatilization and sorption are expected 
to be low (Rúa-Gómez & Püttmann, 2012). Maximum detected concentration found 
was 64 ng/L and median concentration 3.8 ng/L, which is acceptable when compar-
ing it to detected concentrations in river water in UK which exceeded single µg/L 
(Baker & Kasprzyk-Hordern, 2011). Tramadol is occasionally termed as a mild-
opioid, similar to codeine (Olsson et al., 2017). It’s potential for dependency is con-
sidered low (WHO, 2014), however, growing abuse rates among young adults are 
of rising concern (Olsson et al., 2017). Just recently in January 2018, a local Swe-
dish newspaper reported the confiscation of great amounts of tramadol in Uppsala 
and that smuggling of tramadol increased strongly (Lindqvist, 2018). This indicates 
that Lake Mälaren might be affected by increasing tramadol consumption rates and 
the compound should be part of future monitoring programs. 
Tolyltriazole is a corrosion inhibitor frequently used in dishwasher detergents 
and in vehicle/aircraft antifreezing products; it belongs to the group of benzotriazole 
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and is associated with high solubility in water, low biodegradability as well as low 
sorption abilities (Giger et al., 2006). Maximum detected concentration is 60 ng/L 
(Ekoln 30 m, Feb ‘17) and median concentration is 22 ng/L. This is below the con-
centration found in Swiss lakes, with ranges up to a few µg/L, however, its high 
frequency of detection is well in agreement with studies investigating river water 
(Giger et al., 2006; Wang et al., 2016). Nearby located airports – Arlanda airport is 
situated to the east of Lake Mälaren – may considerably contribute to the occurrence 
in surface water (Giger et al., 2006). The high and frequent detected concentrations 
in surface water raise the question about its presence in drinking water. This was 
confirmed by Janne et al. and Wang et al. (2011; 2016).  
Bicalutamide is next to ifosfamide one of the antineoplastic drugs detected in 
Lake Mälaren. Methotrexate was not detected. Bicalutamide is an antiandrogen used 
for 79% of prostate cancer treatment in Sweden and said to be difficult to biodegrade 
(Besse et al., 2012; Grundmark et al., 2012) which explains the continuous detection 
in all the sampling points. A maximum concentration of 12 ng/L and median con-
centration of 2.3 ng/L is tolerable and seems not to raise high toxicological concerns 
(Besse et al., 2012; Santos et al., 2017). 
For 34 of 51 compounds, maximum detected concentrations were compared with 
predicted critical environmental concentrations (CEC) calculated by Fick et al. 
(2010). CECs facilitate a quick and simplified approach to evaluate the potential of 
individual compounds to cause adverse pharmacological effects at certain water 
concentrations. This methodology is based on the correlation of plasma concentra-
tion in exposed fish with human therapeutic plasma concentrations (Fick et al., 
2010). All maximum concentrations were well below the CECs. However, no CEC 
values were available for some of the most frequent and highest detected com-
pounds, for instance, DEET, nicotine, sulisobenzone, tolyltriazole, valproic acid, the 
three parabens and for the other industrial chemicals.  
None of the detected concentrations represent an acute risk for humans or fauna 
according to current states of knowledge. However, high insecurities regarding 
chronic toxicity, adverse effects on non-target organisms and synergistic effects still 
remain and should not be disregarded.  
Additional information for the 50 OMPs regarding CAS number, molecular for-
mula, charge and hydrophobicity is shown in table A5 in the appendix. 
3.2.2 Spatial distribution 
In total 11 different sampling locations distributed around Lake Mälaren were part 
of the study: Ekoln, Skarven, Görväln, Västeråsfjärden, Blacken, Prästfjärden, 
Svinnegarnsviken, Granfjärden, Ulvhällsfjärden and Södra Björkfjären. Only 5 lo-
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cations, including different sampling depths for two of the locations, were consist-
ently collected throughout most of the period: Ekoln (0.5 m, 15 m, 30 m), Görväln 
(0.5 m, 15 m, 40 m), Västeråsfjärden (0.5 m), Galten (0.5 m), Skarven (0.5 m). 
For a better understanding of the results, it is important to point out, that there 
are considerable differences between the sampling locations regarding the residence 
time of the water, incoming flow rates, surrounding land use, volume and depth. 
Depending on the residence time, some basins are more prone to higher concen-
trations of pollutants than others, due to limited self-cleaning abilities and different 
background levels of substances (Sonesten et al., 2013). These self-cleaning abili-
ties are somewhat at the same time basin dependent natural attenuation mechanisms. 
In the course of this, the volume and depth of a basin are relevant factors since the 
extent of larger bottom areas interacting with the surface water, the extent of wind 
and waves having an impact and the process of sedimentation do affect biodegrada-
tion, sorption and photodegradation (Wallin et al., 2000). 
For various purposes, Mälaren is divided into 6 theoretical basins (see figure 2). 
The westernmost and smallest basin Galten in terms of volume receives about 46% 
of the incoming water and has therefore the shortest residence time together with 
the easternmost basin, which is where Mälaren and its outlet is linked with the Baltic 
sea (theoretical turnover rate is between 0.5 – 1 month) (Sonesten et al., 2013). Väs-
teråsfjärden, Blacken and Granfjärden form together the second biggest basin in 
terms of volume and have a theoretical water turnover rate of roughly 7 months. The 
biggest basin is represented by Svinnegarnsviken, Ulvhällsfjärden, Prästfjärden and 
S. Björkfjärden and is characteristic for the longest residence time with 1.8 years. 
Ekoln and Skarven form the most northern basin with a residence time of 1.2 years, 
which leaves the last basin Görväln with a residence time of roughly 5 months 
(Wallin et al., 2000). 
 There are two main flow directions of the water in Mälaren: one coming from 
the west moving to the east and the other coming from the north and continuing to 
the south. The ultimate mixing of those masses occurs at Görväln (Wallin et al., 
2000).  
The sampling sites Västeråsfjärden and Ekoln are most closely located to big 
cities and are therefore subject to rather direct pollution. In contrast, Görväln, Galten 
and Skarven are rather remote areas. The water for the drinking water plant is with-
drawn at Görväln, which is approximately 50 km away from Ekoln. 
Only two sampling months, namely September ’17 and April ’18, covered all 11 
different sampling locations that were part of the study, the spatial distribution of 
OMPs in the entirety of Mälaren was addressed in only these two months. In general, 
differences between locations were shown in different concentration levels and dif-
ferent absolute numbers of OMPs that were detected of the total 50 analyzed OMPs 
at a specific location. 
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Västeråsfjärden is the sampling location where the highest sum concentration 
and most of the OMPs were detected, followed by Ekoln and Svinnegarnsviken (see 
table 2). Densely populated areas usually have greater adverse impacts to surround-
ing water bodies due to an elevated usage of pharmaceuticals/chemicals (Luo et al., 
2014). This, together with the fact that Ekoln and Västeråsfjärden are affected by 
incoming rivers carrying WWTP effluent water, can explain the findings. 
Table 2. Differences of sampling locations regarding sum of concentrations and the absolute number 
of OMPs detected above LOQ of total 50 OMPs. All values constitute average values from the two 
sampling months September ’17 and April ’18. 
Location 
Sum OMP (ng/L) 
and standard devia-
tion 
Absolute number of 
OMPs detected > LOQ 
(n=50) 
Västeråsfjärden 234 (±27) 33 
Ekoln 161 (±66) 30 
Svinnegarnsviken 141 (±14) 28 
Skarven 134 (±4.8) 24 
Ulvhällsfjärden 90 (±4.7) 21 
Blacken 83 (±3.1) 25 
Galten 79 (±8.0) 23 
Görväln 79 (±8.3) 21 
Granfjärden 76 (±3.5) 22 
Prästfjärden 53 (±10) 15 
S. Björkfjärden 48 (±8.1) 18 
S. Björkfjärden and Prästfjärden are at the bottom of the list (see table 2), showing 
that these are the location with the lowest sum concentrations and the least number 
of OMPs being detected. The latter is situated most centrally in the lake basin so 
that effects of typical point sources are negligible. Similar holds true for S. Björk-
fjärden.  
It needs to be stressed out that these observations ignore seasonal trends and 
compound specific behaviors. The compositions of OMPs are very different for each 
location. Furthermore, for this interpretation only two sampling events for each lo-
cation were included. Further sampling is needed. However, when looking at the 
five sampling locations which were continuously sampled (Västeråsfjärden, Ekoln, 
Skarven, Gärväln, Galten) for the entire sampling period, the same trend could be 
observed with Västeråsfjärden and Ekoln being the most polluted sites. 
With Ekoln being the northernmost part of Lake Mälaren, it can be expected that 
the OMP concentration is diluted while continuing more south. Indeed, this trend 
can be observed: sum OMP concentrations decreased by a factor of 0.83 at Skarven 
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and by a factor of 0.49 at Görväln compared to Ekoln. These numbers merely indi-
cate the trend of dilution; they are not universally valid and don’t allow derivations 
for separate OMP observations or different sampling months. 
Furthermore, water mass movement and mixing activities seem to affect the con-
centrations at sampling locations as well. Lamotrigine and carbamazepine are two 
highly correlating compounds (see paragraph 3.3). In Ekoln and Västeråsfjärden a 
clear linear relationship between those two compounds can be observed (see figure 
A1 in the appendix). This pattern is still shown for Skarven, however, not anymore 
for Görväln. The mixing of the north-south and west-east stream hamper the original 
observed prevailing pattern of linearity. The bigger the distance from discharging 
point sources, the more difficult to observe these patterns and trends since the effect 
of water chemistry, water movement and natural attenuation mechanisms gets 
stronger and becomes very complex. 
3.2.3 Seasonal variations 
Samples were collected in eight different months (February, April, May, July, Au-
gust, September and November in 2017 and April in 2018). The seasons were clas-
sified based on water temperature (figure 6). 
Unfortunately, water temperature data for November was missing. Since there 
was a sharp temperature drop compared to September – first snow events occurred 
Figure 6. Vertical distribution of water temperature for different locations throughout the sampling period 
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as shown in the picture (figure 1) from the sampling day – the November sampling 
is classified as late-autumn/winter event. Ultimately, there are three periods repre-
sented: late autumn-winter (November, February), spring (April 2x, May) and sum-
mer-early autumn (July, August and September). For convenience only, these peri-
ods will be simply addressed as winter, spring and summer. 
Differences between the seasons are apparent by, amongst others, concentrations 
and detection frequencies of a sepcific OMP during a specific season. The latter is 
termed here as seasonal detection frequency. When a seasonal detection frequency 
of an OMP is higher than the total detection frequency of that OMP throughout the 
entire sampling period, it implies that the compound was found more frequently in 
that very season than in the other seasons. Both approaches to assess seasonality are 
incorporated in the figures presented on the next pages, showing for winter, spring 
and summer the top 20 OMPs with the highest detected concentrations (figure 7, 8 
and 9). By comparing those three seasonal top 20 highest compound figures, it is 
recognizable that there are 14 reoccurring compounds: bicalutamide, caffeine, car-
bamazepine, cetirizine, lamotrigine, lidocaine, losartan, metoprolol, sulisobenzone, 
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Figure 7. Top 20 highest detected OMPs during winter sampling events. The figure illustrates the highest detected concentra-
tion and median concentration in winter. Seasonal detection frequency indicates how often a specific compound was detected 
in the winter months and total frequency of detection is associated to the entire sampling period. (n=17) 
 
39 
 
3% 
(1%)
55% 
(36%)
100% 
(100%)
100% 
(100%)
6% 
(2%)
100% 
(100%)
97% 
(99%)
9% 
(4%)
94% 
(87%) 79% 
(62%) 100% 
(88%)
97% 
(82%)
55% 
(37%)
58% 
(46%)
85% 
(68%)
100% 
(100%)
67% 
(62%)
100% 
(85%)
91% 
(71%)
24% 
(18%)
0
20
40
60
80
100
120
140
2590
2600
co
n
ce
n
tr
at
io
n
 n
g
/L
Median concentration ng/L
Maximum concentration ng/L
Seasonal frequency of detection %
Total frequency of detection (%)
100% 
(100%)
11% 
(18%)
23% 
(36%)
100% 
(100%)
100% 
(100%)
100% 
(99%)
77% 
(87%)
57% 
(62%)
14% 
(37%)
49% 
(71%)
69% 
(82%)
100% 
(100%)
100% 
(100%)
69% 
(62%)
80% 
(88%)
80% 
(88%)
74% 
(86%)
9% 
(8%)
71% 
(85%) 57% 
(68%)
0
10
20
30
40
50
60
70
80
90
100
110
120
co
n
ce
n
tr
at
io
n
 n
g
/L
Maximum concentration ng/L
Median concentration ng/L
Seasonal frequency of detection %
Total frequency of detection (%)
Figure 8. Top 20 highest detected OMPs during spring sampling events. The figure illustrates the highest detected concen-
tration and median concentration in spring. Seasonal detection frequency indicates how often a specific compound was de-
tected in the spring months and total frequency of detection is associated to the entire sampling period. (n=33) 
 
Figure 9. Top 20 highest detected OMPs during summer sampling events. The figure illustrates the highest detected concen-
tration and median concentration in summer. Seasonal detection frequency indicates how often a specific compound was de-
tected in the summer months and total frequency of detection is associated to the entire sampling period. (n=35) 
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tolyltriazole, tramadol, tris(2-butoxylethyl)phosphate, valproic acid and venlafaxine 
These are the compounds that were present with the highest concentration through-
out the entire year. This does however not automatically imply that there are no 
fluctuations within the concentration. The detected concentration is simply just al-
ways higher than the rest of the 50 compounds. These compounds should certainly 
be taken into account for future OMP monitoring programs in Lake Mälaren. 
Seven compounds show no considerable annual fluctuations and therefore no 
seasonal patterns in detection levels: bicalutamide, carbamazepine, DEET, 
lamotrigine, metoprolol, oxazepam and tolyltriazole. These seven compounds were 
identified with a quite similar approach as the determination of the performance 
parameter repeatability by considering the standard deviation of the seasonal aver-
age concentration for a respective compound. The specific criteria used to identify 
these compounds is described in appendix 2. 
When looking at the different concentration levels of a compound for the differ-
ent seasons, it could be observed that usually higher concentrations of an OMP were 
found in the spring sampling months, followed by the winter season. In addition, a 
specific compound was in general more frequently detected in spring and winter 
than in the summer months. A similar trend could be observed when looking at the 
number of compounds that were detected at a specific season: all of the 50 com-
pounds were found in spring, while a few compounds were not detected at all in 
winter or summer. 
Some considerable differences are shown for single target analytes and pointed 
out in the following. Nicotine was detected for 51% of the sampling points in the 
summer time but for 0% and 3% in winter and spring time, respectively. Atorvas-
tatin, an antilipidemic agent, was detected for 36% in the spring samples but only to 
6 % in both winter and summer. Pyrimethamine, an antimalarial, was detected in 
almost a third of the winter samples (24%), and only once during the spring months, 
which is also the total highest concentration of 0.070 ng/L. Valsartan, an antihyper-
tensive drug, was detected in roughly one third of the spring samples (33%) and 
only in 11% in the summer ones, and still, the concentrations detected in summer 
were that high, so that it has the second highest median concentration value of 21 
ng/L, as illustrated in figure 9. Methylparaben was detected in 65% of the winter 
sampling months, whereas spring and summer months account for 30% and 20%, 
respectively. Lidocaine, a local anesthetic,was detected in all spring samples and 
76% during winter sampling events and 71% during summer. Although diclofenac, 
a NSAID, was found in 55% of the spring samples, the highest concentration of 13 
ng/L and also the only time within the top 20 occurred during winter sampling 
events (detection frequency 47%). Diclofenac was detected in only 14% during 
summer time. Fluoxetine, an antidepressant, was detected only once in spring 
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throughout the entire sampling period. In fact, the concentration was even quite 
high: 53 ng/L.  
The highest detected concentration of an OMP for each season together with 
calculated median concentrations and seasonal detection frequencies can be found 
in table A6 in the appendix. 
For some compounds, reasonable explanations can be found. For instance, the 
highest concentration found for cetirizine, an antihistamine, was found in spring 
time with 33 ng/L and the lowest maximum concentration of the three seasons was 
found in winter time with 8.4 ng/L. Cetirizine is widely used to treat allergy symp-
toms caused by hay fever so that its peak usage is usually in springtime when plant 
pollens are most intense (Kosonen & Kronberg, 2009). However, in contrast, for 
fexofenadine, the second antihistamine analyzed in the course of the present study, 
the highest concentration was detected in summer time with 6.9 ng/L, followed by 
spring with the highest detected concentration of 5.3 ng/L and 3.6 ng/L in the winter 
time (see figure 10). Both compounds are over-the-counter (OTC) drugs, however, 
an antihistamine reviewing paper states that cetirizine is contained in 60% of anti-
histamine medication, whereas fexofenadine comprises merely 4% (Kosonen & 
Kronberg, 2009). Biodegradation rates are low and it is suggested that cetirizine is 
excreted to 100% in unmetabolized form and biodegradation is very limited (de 
Figure 10. Seasonal trend of detected concentrations for the two antihistamines cetirizine and 
fexofenadine. 
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Graaff et al., 2011). Variances of the concentrations between seasons are for cetiriz-
ine much higher than for fexofenadine. Therefore, it is assumed that the concentra-
tions obtained for fexofenadine are derived to a higher extent from constant back-
ground levels than cetirizine.  
Literature agrees with the overall low concentration trend of OMPs in the sum-
mer time (Vieno et al., 2005; Daneshvar et al., 2010a; b). Higher solar radiation, no 
ice covers and higher temperatures are factors responsible for increasing natural at-
tenuation rates. Additionally, in winter lower removal efficiencies from WWTPs 
were reported in Vieno et al., (2005) due to the temperature dependent biodegrada-
tion process, which eventually caused higher OMP discharges into receiving water. 
However, Fernández et al., (2014), concluded that seasonal removal efficiencies of 
WWTPs are very much compound dependent. A counteracting factor for this obser-
vation is generic increased precipitation during winter and therefore dilution of an-
alytes (Azzouz & Ballesteros, 2013). A closed ice cover will lead to a time lag of 
this effect, though. Swedish springs are still quite cold, water temperatures as shown 
in figure 6 are just starting to increase and solar radiation intensity did not reach its 
peak, yet. Additionally, accumulated concentrations during the winter months might 
explain the high occurrence patterns of OMPs during the spring time.  
April is the only month that was sampled twice, once in 2017 and once in 2018. 
This allows direct comparison. 7 times a compound was detected at one of the April 
sampling events while it was not detected in the other year. Excluding those 7 cases, 
higher maximum concentrations were detected to 55% in April ’17 and 45% in April 
’18. A bigger gap between the years can be observed while looking at median con-
centrations. Here, April ’17 obtained considerable higher median values than April 
’18 (84% vs. 16%). Looking at the frequencies of detection a shift in favor of April 
’18 is apparent, where compounds were detected more frequently to 81% of the total 
sampling points. The main reason for lower concentrations in April ’18 is due to the 
dilution mechanism. Precipitation in summer and winter 16/17 was scarce so that 
concentrations assumedly accumulated during winter months. In fall ’17 there were, 
however, some heavy rainfall events, which ultimately led to a sudden dilution ef-
fect. Furthermore, winter 17/18 was endowed with an abundance of snow, whose 
thaw caused further dilution (weather information was derived from open data by 
the Swedish Meteorological and Hydrological Institute (SMHI)).  
It is important to point out that data points for the winter season were limited. It 
is recommended to continue with further even more frequent sampling events during 
the winter time to support the above made hypothesis. 
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3.2.4 Vertical distribution in the water column 
Lake Mälaren is unique by its diverse basin characteristics, one varying factor being 
the depth. As an entirety, Lake Mälaren has a mean depth of 12.7m and 20% of the 
lake area is shallow (<3m) (Sonesten et al., 2013).  In the course of this study, two 
of the deepest lake basins, Ekoln and Görväln, were taken and analyzed from dif-
ferent levels (0.5 m, 15 m, 30/40 m). Maximum depth for Ekoln is 50 m and for the 
Görväln basin 63 m (Sonesten et al., 2013). The maximum depth from the specific 
sampling point at these two basins is not known.  
Throughout the season different mixing states at the lake occur. Temperature 
determines water density, which ultimately affects the stratification of lakes. How-
ever, the major driver for heat exchange is wind (Kirillin & Shatwell, 2016). As it 
is seen in figure 6, there is a clear temperature gradient in the months July, August 
and September between the different water sampling depths. In contrast, April and 
May show little variations which imply well mixed water layers. For the month with 
the coldest water temperatures, February, no large temperature gradient is seen. 
However, one has to consider, that Swedish lakes are usually still covered by ice at 
that time, so that external effects, such as solar radiation, precipitation and wind are 
mostly negligible due to major isolation.  
Although samples from different depths were collected from Görväln and Ekoln, 
only samples from Ekoln were considered for assessing concentration gradients, as 
the compounds are more frequently detected (see paragraph 3.2.2.) and the dilution 
effect is in general lower as in Görväln due to a higher direct impact of the incoming 
river Fyrisån, which carries the effluent from a WWTP. 
When looking at the vertical distribution of concentration levels in the water col-
umn for some sampling months no considerable fluctuations of OMP concentrations 
were observed. This was the case for both April sampling events (2017 and 2018) 
and November. High variations of OMP concentrations occurred in February and 
May, moderate variations in July and August and low variations in September. This 
observation does not entirely agree with the measured temperature gradient patterns 
for the different months (see figure 6) but in general explains well typical stratifica-
tion processes in surface water.  
Clear patterns regarding the vertical distribution of OMP concentrations in the 
water column were only found for the sampling months February and May. In Feb-
ruary, sum OMP concentration of the deepest water column (30m) was by a factor 
of 1.9 and about 1.8 times higher than the sum OMP concentration of the sample 
depth 0.5 m and 15 m, respectively (ΣOMP concentration in ng/L: 231 (0.5 m); 249 
(15 m); 441 (30 m)). In May, the highest sum OMP concentration occurred at the 
0.5 m water level, which was about 1.5 times and 1.9 times higher than the sum 
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OMP concentration of the sample depths 15 m and 30 m, respectively (ΣOMP con-
centration in ng/L: 499 (0.5 m); 269 (15 m); 330 (30 m)). Hence, there is not a steady 
increasing or decreasing concentration gradient in May as it was the case for Febru-
ary. No clear trends were observed for any of the other sampling months.  
The calculated orders of magnitude for the months February and May need to be 
treated very carefully as these numbers are strongly generalised and don’t consider 
compound specific fluctuations. 
In winter time, the water is usually much denser, and in case of ice coverage, 
water from inflowing streams will sink and not mix with upper levels, as it was 
observed in Lake Tegel in Germany (Schimmelpfennig et al., 2016). This might be 
the reason for Lake Mälaren as well. Clearly much higher concentrations were de-
tected in the deepest water level in February. Considering that most fish usually stay 
in the theoretical warmer bottom level, there might potentially be an increased risk 
of exposure of fishes by OMPs in the winter. 
The major reason that no concentration gradients could be observed for the April 
months and November are probably the well mixed layers during that time. In 
warmer months incoming flows tend to stay in the surface water level, which might 
be the reason for the gradient patterns in May, however it doesn’t explain why no 
clear gradient patterns were observed for the other summer months. August and 
September seem to be transition months, although water temperature between the 
depths still vary. This leads to the assumption that temperature gradients are not the 
only driver for vertical occurrence patterns of OMPs. 
No statistical test was conducted, so it is not known if the findings of vertical 
distribution are significant. However, the results were well comparable to those at 
Lake Tegel in Germany. Further research regarding environmental fluid dynamics 
and more frequent sampling events are needed to draw clear conclusions. 
3.3 Correlations between OMPs 
The numerous OMPs being used and ultimately released into the environment calls 
for the identification of correlating compounds to facilitate monitoring programs, 
fate and transport models. Keeping in mind that constantly newly designed chemi-
cals are introduced to the market with no discharge regulation or environmental 
quality standards being set-up, knowledge about correlations would allow to re-
spond more quickly and address these substances more effectively. However, this is 
easier said than done. Simply having two OMPs belonging to the same therapeutic 
group or having similar physical-chemical properties, for instance, doesn’t automat-
ically imply similar behavior.  
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A principle component analysis (PCA) was performed in the present study to 
find some relationships between the analyzed compounds. PCA is a useful tool that 
aims to find underlying/latent variables which would otherwise be very difficult to 
see. The considered values for PCA form independent linear clusters that cover the 
variance of the data the best. These combinations are summed up in so-called prin-
ciple components. The first and second principle component (PC) are the ones ex-
plaining the data the best.  
To reduce the complexity of the study, sample points from different depths be-
side surface water (0.5m) were excluded and only compounds with a frequency of 
detection (>50%) were chosen for the PCA.  
The first two PCs account for 70% of the variation in the data, broken down in 
55% for PC1 and 15% for PC2. To describe 85% of the data four PC’s are needed. 
The loading plot (figure 11 B) illustrates the correlations between the original vari-
ables and the first two PCs. The figure shows that all variables correlate positively 
Figure 11. Summary plot of PCA analysis indicating cor-
relations between variables: A) Score plot B) Loading plot. 
(Abbreviations: E=Ekoln; V=Västeråsfjärden; S=Skarven, 
SV=Svinnegarnsvicken. Numbers constitute the sampling 
month: 2=February; 4.1=April’17; 4.2=April’18; 5=May, 
7=July; 8=August; 9=September; 11=November. For over-
view purposes, only relevant sample points are labelled at 
the score plot, excluding those from less polluted sampling 
locations (e.g. Görväln, Galten)). 
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to the first PC as they are directed to the right within the PC1 dimension (x-axis). 
The distribution within the PC2 dimension is more spread out, showing positive and 
negative correlations. The strong positive correlation of the OMPs with PC1 is 
driven by the samples from Ekoln and Västeråsfjärden as shown in the score plot.  
Some of the compounds previously identified to occur to consistent levels during 
the year are located closely together (carbamazepine, lamotrigine, tolyltriazole, 
DEET and bicalutamide). The original established criteria (Appendix 2) to assort 
these OMPs was just not met by fexofenadine and lidocaine; the two compounds 
positioned directly next to the others. This arises the question at which point a com-
pound can be classified as consistent and what are the specific criteria to do so. To 
my current knowledge, no valid official criteria do exist. The same applies to the 
evaluation of seasonality.  
So what are possible underlying variable for these correlation patterns? Cer-
tainly, the persistency and removal efficiency of the OMPs relating thereto, play an 
essential role. For OMPs to occur in such a big water compartments as Lake Mä-
laren, high persistence to removal mechanism is basically a prerequisite in the first 
place. Provided, that the effluent of the WWTP is the primary pathway of OMPs to 
enter the aquatic environment. Caffeine is a compound which is generally removed 
well in WWTPs, which puts it somehow in an oppositional position to, for instance, 
carbamazepine. No acceptable correlation was found for caffeine. The possibility 
that contamination might be an issue cannot be excluded. 
In general, adjacent compounds indicate a correlation between those very com-
pounds. However, one cannot simply jump to conclusions, as multiple interactions 
between the variables will cause shifts. Therefore, partial least square (PLS) analysis 
was performed to explore correlations between two compounds. In table 3 only the 
highest found significant correlations between two compounds are presented.  
Strong correlations are shown between the same group of consistent occurring 
compounds, with lamotrigine and carbamazepine being able to explain 91% of the 
variation of the other. Antiepileptics, beta blockers, antihypertensives and antide-
pressants seem to correlate best with those compounds from the same therapeutic 
group. However, there are some crossovers. For instance, even though cetirizine and 
fexofenadine do significantly correlate with each other (41%), another compound 
seem to explain the respective variation even better. Metoprolol the compound 
which was also assorted to that very group, does not correlate with any of those 
compounds significantly, which is also shown in the loading plot. In contrast, tol-
yltriazole an industrial compound does very well correlate with carbamazepine, 
lamotrigine, oxazepam and DEET. Tramadol and tris(2-butoxyethyl)phosphate, two 
seemingly complete different compounds (an analgesic and flame retardant), are 
able to explain 81% of each other’s variation. This is very surprising. No pKa value 
for the flame retardant was found, the chemical structures are very different and the 
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Kow value is 3.01 for tramadol and 3.75 tris(2-butoxyethyl)phosphate, indicating 
moderate and high hydrophobicity; so no apparent link between the compounds can 
be found. Further investigation is needed to understand this correlation.  
Table 3. Correlations between compounds according to PLS analysis by statistical program JMP. 
Only the best possible statistical significant correlation for each OMP is presented. Reciprocal best 
correlations between OMPs are marked with * 
Correlating OMPs 
Variation explained 
in percent 
Lamotrigine Carbamazepine 91% (*) 
Venlafaxine Mirtazepine 83% (*) 
Bicalutamide Carbamazepine 82% 
Tramadol Tris(2-butoxyethyl)phosphate 81% (*) 
Tolyltriazole Carbamazepine 80% 
Citalopram Venlafaxine 80% 
Lidocaine Bicalutamide 78% 
Oxazepam Carbamazepine 74% 
Lorsartan Sulisobenzone 74% (*) 
Fexofenadine Carbamazepine 67% 
Metoprolol Propranolol 67% (*) 
DEET Carbamazepine 66% 
Cetirizine Oxazepam 65% 
Bisoprolol Irbesatan 46% (*) 
Caffeine Losartan 20% 
Dibutyl phosphate none - 
The two industrial chemicals tolyltriazole and tris(2-butoxyethyl)phosphate are not 
even nearly as well documented as carbamazepine and other ubiquitous termed 
OMPs regarding their occurrence, toxicity and degradation potential. Having such 
strong correlation patterns with carbamazepine and tramadol, respectively, might 
already give some better insight into the fate and transport of these compounds. The 
fact, that both industrial compounds were successfully quantified in the multi-resi-
due method of this study is a novelty. Continuing consideration and investigation in 
future analysis is recommended. 
It needs to be pointed out, that such observed correlations have to be treated very 
carefully, though. Too much is still not known about the behavior of OMPs to elu-
cidate every angle and every variable of seemingly correlating compounds. Per-
forming this analysis in an entirely different matrix, such as wastewater, sediments 
or drinking water will probably lead to a different outcome. Different underlying 
variables will account for different principle components. 
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3.4 Correlations between OMPs and water chemistry of 
Lake Mälaren 
Due to the complexity of environmental samples, several water chemistry parame-
ters were incorporated into the PCA in an attempt to find a better principle compo-
nent. This included data about Chlorophyll-a content, water temperature, total phos-
phor, silicium content, oxygen content, absorbents, turbidity and visible depth. The 
data was provided by the Department of Aquatic Science and Assessment, Geo-
chemistry Section, SLU which was obtained as part of routine monitoring programs 
at Mälaren. 
Contrary to the assumption that this approach will allow explaining the behavior 
of the analyzed OMPs to a better degree, no correlations were observed. In fact, the 
best component combination explained even much less. No data for this outcome is 
presented here. 
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The study aimed to comprehensively investigate the current OMPs pollution status 
of Lake Mälaren during a one year study. The profound data interpretation consid-
ered several aspects such as spatial and vertical distribution, seasonal variations and 
correlations between OMPs. It was shown that the occurrence of OMPs in surface 
water are highly dependent on numerous factors; proximity to point sources, dilu-
tion factor, lake basin characteristics, to name but a few. This study contributed 
therefore to a better understanding of fate and transport of OMPs in large water 
bodies. Several aspects of this study support findings of ongoing research projects 
and should provide new impetus for further research. OMP exposure hotspots in 
Lake Mälaren are clearly located where WWTP effluents are mixed with the receiv-
ing water body. In total 122 compounds were evaluated in the present study, con-
sisting of 80 pharmaceuticals, 19 industrial chemicals, 7 personal care products, 3 
pesticides, 3 vitamins, 3 parabens, 2 artificial sweeteners, 2 stimulants, 1 contrast 
medium, 1 opioid and 1 isoflavone. 
 Although dilution and natural attenuation effects are considerably degrading 
concentrations of OMPs once they are introduced to the aquatic environment, this 
study was still able to detect 50 OMPs above LOQs by the means of a simple, reli-
able, fast and sensitive method using UPLC-MS/MS and SPE. Concentrations were 
below acute toxicity levels. However, the regularity of detections of most target an-
alytes during the one year sampling period poses the question of long-term toxicity 
risks for aquatic organisms, where adverse effects are insidious and irreversible once 
they are manifested. Besides that, combined effects when OMPs are interacting with 
each, commonly termed as synergistic or cocktail effect, are additionally important 
to consider but very difficult to assess. The presented data is no exemption in this 
regard showing varied composition profiles of OMPs for the sampling points in 
terms of concentration levels and simultaneously detected compounds. 
Regular follow-up sampling events, especially with more frequent winter sam-
pling are needed for an improved view of occurrence and seasonality of OMPs in 
4 Conclusion and outlook 
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Lake Mälaren and in order to support the findings of this study. Furthermore, ongo-
ing optimizations of analytical methods to incorporate additional OMPs such as in-
dustrial chemicals with good performance parameters are needed to facilitate further 
investigations. Although no specific patterns for detected concentrations regarding 
selected water chemistry data were found, flow models, mixing models or extensive 
studies addressing the relationship of OMP occurrence with lake-specific mecha-
nisms (e.g. wind-driven circulation, stratification, removal efficiencies, natural at-
tenuation mechanisms, residence times of lake basins etc.) will help to find patterns 
and to draw significant conclusions. There is much potential for future research and 
this study hopes to provide a basis to do so.  
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Table A1. Average, maximum and minimum LOQ's from positive compounds 
OMP Average MAX MIN 
Atenolol 0.089 0.29 0.061 
Sotalol 0.15 0.56 0.11 
Nicotine 0.062 0.22 0.041 
Metoprolol 0.083 0.27 0.046 
Atorvastatin 0.19 0.4 0.1 
Carbamazepine 0.032 0.066 0.02 
Cetirizine 0.035 0.07 0.028 
Citalopram 0.01 0.02 0.0076 
Mirtazapine 0.025 0.051 0.019 
Oxazepam 0.033 0.067 0.025 
Pyrimethamine 0.018 0.036 0.014 
Lamotrigine 0.29 0.58 0.23 
DEET 0.093 0.2 0.076 
Bezafibrate 0.28 0.45 0.23 
Sulisobenzone 0.3 0.49 0.25 
Dibutyl phosphate 0.22 0.36 0.18 
Tolyltriazole 0.98 1.6 0.81 
Ifosfamide 0.075 0.12 0.062 
Bicalutamide 0.023 0.048 0.012 
Bisoprolol 0.012 0.024 0.0066 
Clozapine 0.022 0.041 0.017 
Diazepam 0.023 0.044 0.018 
Fexofenadine 0.02 0.038 0.016 
Caffeine 0.8 1.6 0.65 
Tramadol 0.07 0.12 0.05 
Valsartan 0.69 1.2 0.5 
Codeine 0.081 0.14 0.059 
Oxycodone 0.085 0.15 0.061 
2,2'-Dimorpholinyldiethyl-ether 0.069 0.12 0.05 
Diclofenac 2 3 1.6 
Ethylparaben 0.19 0.3 0.11 
Propylparaben 0.062 0.09 0.046 
Methylparaben 0.31 0.47 0.23 
Furosemide 1.2 1.8 0.95 
Diltiazem 0.065 0.15 0.029 
Appendix 1 
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Ibuprofen 5 7.4 3.9 
Irbesartan 0.011 0.024 0.0089 
Propranolol 0.025 0.061 0.012 
Lidocaine 0.034 0.13 0.018 
Losartan 0.16 0.29 0.13 
Omeprazole 0.029 0.054 0.018 
Acetaminophen 5 10 3.4 
Amitriptyline 0.067 1.2 0.023 
Valproic acid 3.5 5.1 0.79 
Venlafaxine 0.25 0.54 0.18 
Daidzein 0.49 1 0.37 
Di-(2-ethylhexyl)phosphoric acid 0.12 0.24 0.1 
Tris(2-butoxylethyl) phosphate 0.13 0.27 0.11 
3-(4-Methylbenzylidene)camphor 3.3 6.8 2.1 
Fluoxetine 1.4 4 0.77 
 
Table A2. Matrix effect of positive compounds. Negative values imply suppression, positive values 
enhancement. 
OMP Görväln Ekoln Skarven Galten Västeråsfj. Görväln 2018 
Atenolol -14% 0% 5% -2% -63% 0% 
Sotalol -6% -12% 0% 8% 12% 5% 
Nicotine 31% 40% 50% 47% 29% 39% 
Metoprolol 22% 30% 40% 40% 26% 32% 
Atorvastatin -13% -12% -8% -6% 7% -1% 
Carbamazepine -45% -48% -48% -39% -58% -31% 
Cetirizine -60% -63% -68% -62% -73% -13% 
Citalopram 2% 2% 1% 4% 2% -6% 
Mirtazapine -4% -3% -3% 0% -8% -5% 
Oxazepam -26% -27% -30% -23% -25% -16% 
Pyrimethamine -21% -22% -22% -20% -14% -18% 
Lamotrigine -107% -120% -122% -101% -161% -119% 
DEET -11% -7% -12% -12% -7% -18% 
Bezafibrate -13% -11% -12% -9% -17% 10% 
Sulisobenzone 31% 27% 34% 31% 25% 34% 
Dibutyl phosphate -3% -5% 2% -4% -7% -3% 
Tolyltriazole -4% -12% 2% -14% -2% 1% 
Ifosfamide -18% -21% -18% -15% -15% -5% 
Bicalutamide -2% 0% 2% 5% 38% 13% 
Bisoprolol 5% 7% 7% 10% 34% 0% 
Clozapine 0% -1% -2% 5% 21% -41% 
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Diazepam -19% -15% -18% -13% -8% -11% 
Fexofenadine -2% -2% -3% 1% 20% 11% 
Caffeine -7% -11% -3% -5% 4% 4% 
Tramadol -33% -30% -26% -28% -3% -98% 
Valsartan -19% -17% -19% -8% 1% -25% 
Codeine -24% -16% -15% -15% -11% 8% 
Oxycodone -30% -21% -23% -16% 2% -3% 
2,2'-Dimorpholinyldi-
ethyl-ether -43% -40% -43% -42% -10% -19% 
Diclofenac -30% -39% -22% -27% -28% 13% 
Ethylparaben -52% -52% -45% -47% -35% -16% 
Propylparaben -11% -13% -10% -10% -7% -19% 
Methylparaben -52% -54% -53% -63% -60% -54% 
Furosemide -10% -12% -14% -11% -9% 4% 
Diltiazem -22% -20% -25% -16% -11% -12% 
Ibuprofen -22% -22% -30% -21% -31% -31% 
Irbesartan -14% -16% -14% -23% 5% 0% 
Propranolol 22% 21% 29% 18% 45% 39% 
Lidocaine -23% -117% -25% -22% -18% -22% 
Losartan -9% -7% -7% -7% -2% -12% 
Omeprazole 27% 29% 29% 30% 47% 19% 
Acetaminophen 48% 52% 51% 54% 57% 33% 
Amitriptyline -6% -5% -3% -9% 20% 0% 
Valproic acid -3% 3% 14% 11% -2% -38% 
Venlafaxine -20% 437% -21% -41% -17% -8% 
Daidzein -270% -276% -283% -281% -349% -170% 
Di-(2-ethylhexyl)phos-
phoric acid -280% -251% -246% -263% -275% 21% 
Tris(2-butoxylethyl) 
phosphate -4% -2% 3% -5% 6% 14% 
3-(4-Methylbenzyli-
dene)camphor 16% 14% 15% 10% 15% -7% 
Fluoxetine -3% 1% 1% 2% 6% 9% 
 
Table A3. Relative recovery rate and linearity (R²) of compounds with good relative recovery (60%-
145%) that were not detected above LOQ or excluded. 
OMP Category Type Relative Recovery R² 
Albuterol Pharmaceutical Beta blocker 73% 0.9732 
Terbutaline Pharmaceutical Beta blocker 94% 0.9919 
BAM Pesticide Pesticide 109% 1 
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Chlorzoxazone Pharmaceutical Muscle Relaxant 125% 0.9996 
Climbazole Pharmaceutical Antifungal 94% 0.9844 
Clindamycin Pharmaceutical Antibiotic 94% 0.9989 
Iopromide Contrast medium Contrast medium 104% 0.9972 
Memantine Pharmaceutical Alzheimer 73% 0.9965 
Aceclofenac Pharmaceutical NSAID 88% 0.9967 
Meclofenamic acid Pharmaceutical NSAID 109% 0.9978 
Laurilsulfate Industrial chemical  83% 0.9988 
Thiabendazole Pesticide  78% 0.9848 
Methotrexate Pharmaceutical Anticancer 99% 0.9958 
4-Chloro-3-methylphenol Pharmaceutical Antiseptic 83% 0.994 
Ramipril Pharmaceutical Antihypertensive 104% 0.999 
Metronidazole Pharmaceutical Antibiotic 99% 0.9832 
Metronidazole-OH Pharmaceutical Antibiotic, metabolite 94% 0.9963 
Sulfamethoxazole Pharmaceutical Antibiotic 114% 0.9804 
Trimethoprim Pharmaceutical Antibiotic 88% 0.9854 
Sertraline Pharmaceutical Antidepressant 88% 0.9991 
Carazolol Pharmaceutical Beta blocker 68% 0.9989 
Tributyl citrate acetate Industrial chemical  62% 1 
 
 
 
 
Table A4. Precise sampling information showing 
labels, location, depth and sampling date 
Location Depth [m] Date 
Görväln 0.5 2.27.2017 
Görväln 15 2.27.2017 
Görväln 40 2.27.2017 
Ekoln 0.5 2.20.2017 
Ekoln 15 2.20.2017 
Ekoln 30 2.20.2017 
Skarven 0.5 2.22.2017 
Galten 0.5 2.14.2017 
Väster-
åsfjärden 
0.5 2.20.2017 
Görväln 0.5 4.27.2017 
Görväln 15 4.27.2017 
Görväln 40 4.27.2017 
Ekoln 0.5 4.27.2017 
Ekoln 15 4.27.2017 
Location Depth [m] Date 
Ekoln 30 4.27.2017 
Skarven 0.5 4.27.2017 
Väster-
åsfjärden 
0.5 4.26.2017 
Galten 0.5 4.26.2017 
Görväln 0.5 5.15.2017 
Görväln 15 5.15.2017 
Görväln 40 5.15.2017 
Ekoln 0.5 5.15.2017 
Ekoln 15 5.15.2017 
Ekoln 30 5.15.2017 
Skarven 0.5 5.15.2017 
Galten 0.5 5.18.2017 
Väster-
åsfjärden 
0.5 5.17.2017 
Görväln 0.5 7.18.2017 
Görväln 15 7.18.2017 
Görväln 40 7.18.2017 
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Location Depth [m] Date 
Ekoln 0.5 7.20.2017 
Ekoln 15 7.20.2017 
Ekoln 30 7.20.2017 
Skarven 0.5 7.20.2017 
Galten 0.5 7.19.2017 
Väster-
åsfjärden 
0.5 7.19.2017 
Görväln 0.5 8.15.2017 
Görväln 15 8.15.2017 
Görväln 40 8.15.2017 
Ekoln 0.5 8.15.2017 
Ekoln 15 8.15.2017 
Ekoln 30 8.15.2017 
Skarven 0.5 8.15.2017 
Galten 0.5 8.23.2017 
Västeråsfj, 0.5 8.23.2017 
Görväln 0.5 9.14.2017 
Görväln 15 9.14.2017 
Görväln 40 9.14.2017 
Ekoln 0.5 9.14.2017 
Ekoln 15 9.14.2017 
Ekoln 30 9.14.2017 
Prästfjärden 0.5 9.13.2017 
Prästfjärden 15 9.13.2017 
Prästfjärden 40 9.13.2017 
Skarven 0.5 9.14.2017 
Svinne-
garnsviken 
0.5 9.13.2017 
Södra Björk-
fjärden 
0.5 9.12.2017 
Ulvhällsfjärden 0.5 9.12.2017 
Location Depth [m] Date 
Galten 0.5 9.13.2017 
Blacken 0.5 9.13.2017 
Väster-
åsfjärden 
0.5 9.13.2017 
Granfj. 
Djurgårds U. 
0.5 9.12.2017 
Görväln 0.5 11.21.2017 
Görväln 15 11.21.2017 
Görväln 40 11.21.2017 
Ekoln 0.5 11.21.2017 
Ekoln 15 11.21.2017 
Ekoln 30 11.21.2017 
Skarven 0.5 11.21.2017 
Skarven 0.5 4.25.2018 
Görväln 0.5 4.25.2018 
Görväln 15 4.25.2018 
Görväln 40 4.25.2018 
Södra Björk-
fjärden 
0.5 4.24.2018 
Prästfjärden 0.5 4.24.2018 
Ekoln 0.5 4.27.2018 
Ekoln 15 4.27.2018 
Ekoln 30 4.27.2018 
Svinne-
garnsviken 
0.5 4.24.2018 
Ulvhällsfjärden 0.5 4.24.2018 
Granfj. 
Djurgårds U. 
0.5 4.24.2018 
Galten 0.5 4.24.2018 
Blacken 0.5 4.24.2018 
Väster-
åsfjärden 
0.5 4.24.2018 
 
Table A5. Additional information about compounds showing CAS-number, molecular formula, charge and hy-
drophobicity. Charge and hydrophobicity were derived from pKa and Kow, respectively. Charge: 0=neutral, 
1=anionic, 2=cationic) 
OMP CAS number Molecular formula Charge Hydrophobicity 
Atenolol 29122-68-7 C14H22N2O3 2 low 
Sotalol 3930-20-9 C12H20N2O3S 2 low 
Nicotine 54-11,5 C10H14N2 1 low 
Metoprolol 51384-51-1 C15H25NO3 2 low 
Atorvastatin  134523-00-5 C33H35FN2O5 1 high 
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Carbamazepine 298-46-4 C15H12N2O 1 moderate 
Cetirizine 83881-51-0 C21H25ClN2O3 1 low 
Citalopram 59729-33-8 C20H21FN2O 2 high 
Mirtazapine 85650-52-8 C17H19N3 2 moderate 
Oxazepam 604-75-1 C15H11ClN2O2 1 moderate 
Pyrimethamine 58-14-0 C12H13ClN4 2 moderate 
Lamotrigine 84057-84-1 C9H7Cl2N5 1 low 
DEET 134-62-3 C12H17NO - moderate 
Bezafibrate 41859-67-0 C19H20ClNO4 1 high 
Sulisobenzone 4065-45-6 C14H12O6S 1 low 
Dibutyl phosphate 107-66-4 C8H19PO4 1 moderate 
Tolytriazole 29878-31-7 C7H7N3 2 low 
Ifosfamide 3778-73-2 C7H15Cl2N2O2P 0 low 
Bicalutamide 90357-06-5 C18H14F4N2O4S 0 moderate 
Bisoprolol 104344-23-2 C18H31NO4 2 low 
Clozapine 5786-21-0 C18H19ClN4 1 moderate 
Diazepam 439-14-5 C16H13ClN2O 1 moderate 
Fexofenadine 153439-40-8 C32H39NO4 2 moderate 
Caffeine 58-08,02 C8H10N4O2 0 low 
Tramadol 27203-92-5 C16H25NO2 2 moderate 
Valsartan 137862-53-4 C24H29N5O3 1 high 
Codeine 76-57-3 C18H21NO3 2 low 
Oxycodone 76-42-6 C18H21NO4 2 low 
2,2'-Dimorpholinyldi-
ethyl-ether 6425-39-4 C12H24N2O3 - low 
Diclofenac 15307-86-5 C14H11Cl2NO2 1 high 
Ethylparaben 120-47-8 C9H10O3 2 moderate 
Propylparaben 94-13-3 C10H12O3 2 moderate 
Methylparaben 99-76-3 C8H8O3 2 low 
Furosemide 54-31-9 C12H11ClN2O5S 1 moderate 
Diltiazem 42399-41-7 C22H26N2O4S 2 moderate 
Ibuprofen 15687-27-1 C13H18O2 1 high 
Irbesartan 138402-11-6 C25H28N6O 1 high 
Propranolol 525-66-6 C16H21NO2 2 moderate 
Lidocaine 137-58-6 C14H22N2O 2 low 
Losartan 114798-26-4 C22H23ClN6O 1 high 
Omeprazole 73590-58-6 C17H19N3O3S 1 moderate 
Acetaminophen 103-90-2 C8H9NO2 2 low 
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Amitriptyline 50-48-6 C20H23N 2 high 
Valproic acid 99-66-1 C8H16O2 1 moderate 
Venlafaxine 93413-69-5 C17H27NO2 2 moderate 
Daidzein 486-66-8 C15H10O4 - moderate 
Di-(2-ethylhexyl)phos-
phoric acid 298-07-7 C16H35O4P - 
high 
Tris(2-butoxylethyl) 
phosphate 78-51-3 C18H39O7P 
- high 
3-(4-Methylbenzyli-
dene)camphor  C18H22O - high 
Fluoxetine 54910-89-3 C17H18F3NO 0 high 
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Table A6. Seasonal maximum and median concentrations [ng/L] and seasonal frequency of detection for the 
positive compounds (the higher value within the seasons is marked in bold) 
Season Winter Spring Summer Winter Spring Summer Winter Spring Summer 
OMP 
Seasonal maximum con-
centrations [ng/L] 
Seasonal median concentra-
tions [ng/L] 
Seasonal frequencies of de-
tection 
Atenolol 17 11 3.9 1.65 2.8 1.45 47% 58% 34% 
Sotalol 4.3 2.4 5 3.15 1.64 1.8 12% 6% 9% 
Nicotine n.d. 2.3 2.4 - 2.3 0.545 0% 3% 51% 
Metoprolol 16 15 18 3.95 4.4 2.35 82% 100% 80% 
Atorvastatin  0.4 0.97 1.3 0.4 0.24 0.81 6% 36% 6% 
Carbamazepine 25 27 25 9.6 5.7 6.4 100% 97% 100% 
Cetirizine 8.4 33 13 2.2 5.2 4.6 94% 94% 77% 
Citalopram 5.4 2.6 1.4 0.935 0.49 0.5 59% 70% 57% 
Mirtazapine 3 1.2 0.62 0.63 0.3 0.295 53% 64% 34% 
Oxazepam 8.7 8.6 5.9 3.25 1.6 2.05 82% 100% 80% 
Pyrimethamine 0.038 0.07 n.d. 0.03 0.07 - 24% 3% 0% 
Lamotrigine 130 140 120 26 16 15 100% 100% 100% 
DEET 6.2 8.3 6.8 2.3 1.4 2.6 100% 100% 100% 
Bezafibrate 0.98 2 0.49 0.725 0.565 0.36 12% 36% 9% 
Sulisobenzone 5.9 21 21 2.48 1.85 2.6 35% 67% 69% 
Dibutyl phosphate 5.1 5.8 1.2 0.96 0.715 0.81 71% 67% 31% 
Tolyltriazole 60 44 49 27 17 27 100% 100% 100% 
Ifosfamide 0.41 0.33 0.25 0.205 0.13 0.175 24% 30% 17% 
Bicalutamide 7.9 12 7.4 3 2.2 2.8 100% 100% 100% 
Bisoprolol 0.91 2.5 1.3 0.27 0.39 0.22 76% 88% 66% 
Clozapine 0.37 0.34 0.044 0.125 0.084 0.042 24% 30% 6% 
Diazepam 0.11 0.075 0.08 0.062 0.043 0.053 29% 27% 49% 
Fexofenadine 3.6 5.3 6.9 0.785 0.84 1.85 82% 100% 74% 
Caffeine 17 79 28 9.6 15 13 100% 100% 100% 
Tramadol 64 46 23 16 3.9 2.95 76% 97% 69% 
Valsartan n.d. 6.1 39 - 2.4 20.5 0% 33% 11% 
Codeine n.d. 1.5 n.d. - 1.05 - 0% 24% 0% 
Oxycodone 0.7 1.1 0.58 0.2 0.64 0.345 18% 18% 34% 
2,2'-Dimorpholinyldi-
ethyl-ether 
2.7 1.5 1.4 0.32 0.9 0.38 24% 18% 17% 
Diclofenac 13 9.6 3.9 3.4 3.35 3 47% 55% 14% 
Ethylparaben 0.86 8.6 0.55 0.86 3.95 0.55 6% 18% 3% 
Propylparaben 0.6 1.2 0.5 0.175 0.19 0.145 47% 42% 40% 
Methylparaben 2.2 8.2 2.6 0.83 3.05 1.1 65% 30% 20% 
Furosemide 6.5 6 4.5 5 3.25 3.55 24% 36% 11% 
Diltiazem 0.071 0.11 n.d. 0.071 0.056 - 6% 21% 0% 
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Ibuprofen n.d. 24 n.d. - 15.85 - 0% 6% 0% 
Irbesartan 1 1.2 0.85 0.37 0.43 0.27 41% 79% 54% 
Propranolol 0.46 0.43 0.42 0.27 0.15 0.19 47% 64% 43% 
Lidocaine 33 31 17 4.6 1.5 1.8 76% 100% 71% 
Losartan 5.7 24 20 4.5 4.5 4.2 41% 79% 57% 
Omeprazole 0.13 0.093 0.046 0.13 0.071 0.0455 6% 9% 6% 
Acetaminophen n.d. 4.6 n.d. - 4.6 - 0% 3% 0% 
Amitriptyline 0.18 0.37 0.22 0.18 0.13 0.093 6% 24% 9% 
Valproic acid 32 2600 84 15 21 16.5 29% 55% 23% 
Venlafaxine 17 11 7.8 4.3 1.35 3 76% 91% 49% 
Daidzein n.d. 3.4 2.1 - 2.05 1.7 0% 12% 9% 
Di-(2-ethylhexyl)phos-
phoric acid 
27 24 2.3 1.455 0.505 0.415 24% 24% 11% 
Tris(2-butoxylethyl) 
phosphate 
22 29 8.2 7.4 2.25 1.305 53% 85% 57% 
3-(4-Methylbenzyli-
dene)camphor 
n.d. 13 n.d. - 5.3 - 0% 9% 0% 
Fluoxetine n.d. 53 n.d. - - - 0% 3% 0% 
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Figure 12. Linear relationship of carbamazepine and lamotrigine at different sampling locations [in ng/L] 
71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A2. Home-made cartridges for SPE, showing the different composition of the sorbent 
materials. Developed by Gago-Ferrero et al. (2015b). 
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Criteria for the determination of OMPs without major seasonal fluctuations of the 
detected concentrations 
 
The following equation was used to mathematically identify OMPs without major seasonal 
fluctuations: 
 
OMP fluctuation:    
𝑆𝐷 (?̅?(𝑊𝑖𝑛𝑡𝑒𝑟𝐶); ?̅?(𝑆𝑝𝑟𝑖𝑛𝑔𝐶); ?̅?(𝑆𝑢𝑚𝑚𝑒𝑟𝐶))
?̅? (?̅?(𝑊𝑖𝑛𝑡𝑒𝑟𝐶); ?̅?(𝑆𝑝𝑟𝑖𝑛𝑔𝐶); ?̅?(𝑆𝑢𝑚𝑚𝑒𝑟𝐶))
 × 100 < 15%  
SD = standard deviation 
?̅? = mean 
C = concentration 
 
The basic idea behind this equation is to identify those compounds where the fluctuations 
between seasonal average concentrations (for winter, spring and summer) are limited. This 
approach is similar to the determination of the performance parameter ‘repeatability’ where 
duplicates of a sample are used to assess the repeatability of an analytical procedure. Usually, 
a good repeatability is reached when the calculated value is below 30%. For the purpose of 
identifying the described compounds, however, it was decided to use more stringent criteria 
where the calculated value needed to be below 15%. Furthermore, only little variations be-
tween highest and median concentrations for each season and seasonal detection frequencies 
were accepted.  
Average seasonal concentrations instead of median concentrations were used, as a sym-
metrical distribution of the data is a crucial condition for the consistent regular occurrence 
of a compound. Therefore, high concentrations were given greater importance.  
 
Appendix 2 
